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Multilevel analysis of individual, neighborhood, and health care facility characteristics associated with 
achievement and maintenance of HIV viral suppression among persons newly diagnosed with HIV in New 
York City 
By 
Ellen Weiss Wiewel 
Adviser: Professor Luisa N. Borrell 
Objective 
To investigate the effect of individual, health care facility, and neighborhood characteristics on 
achievement and maintenance of HIV viral suppression, among New York City residents aged 13 years 
and older diagnosed with HIV between 2006 and 2012. 
Methods 
I used individual-level data from the New York City HIV surveillance registry and Case 
Surveillance-Based Sampling, facility-level data from the surveillance registry, and neighborhood-level 
data from the U.S. Census and American Community Survey.  The outcomes of interest were first viral 
suppression after diagnosis (Aims 1 and 3; ≤400 copies/mL) and virologic failure after first suppression 
among persons who achieved suppression (Aim 2; viral load ≥1,000 copies/mL or no viral load test for 12 
consecutive months).  Aim 3 was limited to persons interviewed for Case Surveillance-Based 
Sampling.  Multivariable proportional hazards regressions were used to assess the likelihood of 
suppression or failure for individual, facility, and neighborhood characteristics, accounting in Aims 1 and 2 
for clustering of outcomes. 
Results 
Of 12,547 persons newly diagnosed with HIV in 2006–2010, 44% achieved suppression within 12 
months of diagnosis.  In adjusted analyses, persons 13-49 years old, men, blacks and Hispanics, US-
born, heterosexuals, and persons diagnosed in 2006 and 2008 were less likely to achieve suppression 
than persons 60 years old and older, women, whites, foreign-born, men who have sex with men, and 
persons diagnosed in 2010, respectively.  Suppression rates were also lower among persons who were 
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not eligible for treatment, or who were diagnosed at facilities that diagnosed 10-74 patients per year, were 
screening/diagnosis/referral sites, or within one mile of the person’s home.  No neighborhood factors 
were associated with suppression.  Out of 8,927 persons newly diagnosed with HIV in 2006–2010 who 
achieved viral suppression, 18.2% experienced virologic failure within 12 months of suppression.  After 
adjustment, the following groups were the least likely to maintain suppression: younger persons (<50 
years old vs. ≥60), blacks and Hispanics, US- and US-dependency born persons, heterosexuals and 
injection drug users, persons with CD4 counts ≥500 cells/mL at suppression, persons receiving care at 
facilities that were not large outpatient facilities or large private practices, and residents of high- or very-
high-poverty neighborhoods.  Suppression within 12 months of diagnosis was achieved by 65% of 
persons newly diagnosed with HIV in 2006–2012 and interviewed by Case Surveillance-Based Sampling 
(n=92).  Perceived neighborhood social cohesion was not associated with suppression. 
Conclusions 
Persons who were younger, black or Hispanic, US-born, heterosexual, diagnosed in earlier years, 
not treatment-eligible, living within one mile of their health care facility, diagnosed or cared for at certain 
types of facilities such as those with fewer HIV-positive patients, and living in a higher-poverty 
neighborhood were less likely to achieve and/or maintain suppression.  Assistance with post-diagnosis 
linkage to and retention in care, ART prescribing, or adherence that is targeted to groups with 
characteristics associated with poorer outcomes may improve achievement and maintenance of viral 
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Chapter 1. Introduction 
HIV and viral suppression in the US and NYC 
New York City (NYC) is home to more than 7% of all persons newly diagnosed with HIV in the 
United States (US) each year.[1, 2]  It is recommended that persons newly diagnosed with HIV have their 
viral load (VL) measured as soon as they begin HIV-related medical care and then at least every six 
months.[3]  Acute HIV infection typically is accompanied by very high VL (e.g., >100,000 copies of HIV 
ribonucleic acid, RNA, per milliliter, mL, of blood) which eventually declines to a lower set point that varies 
by individual.  Reduction to low or undetectable levels (e.g., ≤400 copies/mL) is called viral suppression 
and is typically achieved through treatment with antiretroviral therapy (ART).[4]  Because of 
improvements in ART since the mid-1990s, and recommendations that ART should be initiated before 
persons with HIV become immunocompromised, HIV has been transformed from an almost inevitably 
fatal disease to a chronic, manageable condition. In addition, because of these changes, viral 
suppression has become more common than virologic failure (i.e., when VL becomes detectable or 
reaches a high level), among persons living with HIV or acquired immunodeficiency syndrome (AIDS; 
PLWHA).  Provided that the virus is sensitive to the multi-drug regimen chosen and the person is 
adherent, ART suppresses virus quickly (within 24 weeks) and durably.[5, 6]  Achievement and 
maintenance of viral suppression, and avoidance of virologic failure, slows progression of HIV disease,[7] 
and reduces the likelihood of onward sexual transmission.[8]  The 2015 goal of the US National HIV/AIDS 
Strategy is a 20% increase in the proportion of persons virally suppressed within three of the populations 
most affected by HIV (blacks, Hispanics, and gay and bisexual men).[9]  As few as 20% of PLWHA were 
thought to be suppressed in the US in the early 2000s, while today most estimates exceed 50%;[10-14] in 
NYC, it was 59% in 2010.[14]  During 2006-2009, suppression within 12 months of HIV diagnosis in NYC 
increased from 36% to 45%, and maintenance of suppression for 12 months increased over the same 
period from 79% to 86%.[15] 
Summary of the literature and current gaps in knowledge 
Epidemiologic literature has explored factors related to viral suppression and virologic failure 




other than individual demographics and clinical characteristics.[15, 16]  With respect to time 
measurement, most published population-level VL statistics, including those with the recent focus on the 
HIV care continuum, refer only to the most recent VL.[10, 13]  A single VL may indicate neither 
maintenance of suppression (also referred to as sustained suppression) nor virologic failure.[16]  The few 
population-based studies following persons’ viral loads over time have found that substantial proportions 
of those achieving suppression do not maintain it.[15, 17-19]  For example, among newly diagnosed New 
Yorkers achieving suppression, 18% experienced virologic failure within 12 months.[15]  I measured time 
from HIV diagnosis to first viral suppression and time from first suppression to virologic failure, with a 
follow-up time of up to seven years. 
More rapid achievement of suppression, longer maintenance of suppression, and lower failure 
rates have been associated with individual-level demographic characteristics including older age,[13, 15, 
20] male sex,[15, 21-23] non-black race,[13, 15, 24-28] baseline clinical status indicators such as CD4 
count and VL,[15, 29, 30], and more recent calendar year of diagnosis.[15]  For example, in the CDC’s 
Medical Monitoring Project, among persons with HIV on ART, 79% of males achieved suppression as 
compared with 71% of females.[13]  An analysis among newly diagnosed residents of Seattle and 
surrounding King County found that blacks had 15% decreased odds of suppression compared with 
whites, while Hispanics had similar odds as whites.[25] 
Studies of achievement and maintenance of suppression may further benefit from the addition of 
variables describing characteristics of health care facilities where people are diagnosed and receive care 
as well as neighborhoods where people live.  For example, facility characteristics, such as type of clinical 
setting, accessibility including travel distance, support services offered, and physician experience have 
been shown to influence intermediary health outcomes among persons with HIV, including receipt of and 
adherence to ART, both necessary steps for maintenance of viral suppression.[31-35]  Specifically, a 
large sample of US hospitals found lower mortality for patients in dedicated AIDS units relative to those in 
hospitals without these units.[36]  Studies in developing countries have found that clinic distance from 
patient residence influences linkage to care, an important precursor to viral suppression.[37]  I am not 
aware of studies examining the effect of facility distance on HIV-related outcomes entirely within a large 




Neighborhood factors such as lower area-level socioeconomic status have been associated with 
higher rates of diagnosis of HIV or AIDS, delayed care and treatment, and increased mortality.[31, 33, 38-
43]  Additionally, lower perceived neighborhood social cohesion has been associated with lower primary 
care use among older urban adults[44] as well as lower condom use and higher STI rates among urban 
adolescents and young adults[45, 46]. The latter factors (condom use and STI rates) have the potential to 
influence the time from HIV diagnosis to viral suppression.  More broadly, public health researchers have 
characterized social and structural factors, such as individual- and neighborhood-level poverty, as 
fundamental drivers of health disparities and encouraged the inclusion of such broader factors in 
epidemiologic analyses.[47-50]  For example, the Alameda County Study was one of the first 
epidemiologic studies to identify an effect of area-level factors on individual health, and it did so in a 
general population, not a population of persons with HIV: individual mortality risk was found to be higher 
among persons living in high-poverty areas than low-poverty areas, even after controlling for factors 
including individual income.[51]  However, few studies on virologic suppression or failure have examined 
facility or neighborhood characteristics.[31-34]  I assessed the impact of facility and neighborhood 
characteristics on the achievement and maintenance of viral suppression while controlling for individual 
characteristics. 
Individual and facility characteristics associated with achievement and maintenance of viral 
suppression can now be measured by many HIV surveillance registries[15, 25, 52] and will become 
increasingly important as more persons with HIV receive ART and achieve suppression.  Area-level data 
aggregated from individual responses to national data sources, such as the US Census and the American 
Community Survey (ACS), can supplement surveillance data with neighborhood-level variables, and can 
be matched to individual-level surveillance data by patient residence.  I linked data from the US Census 
and ACS with data from the HIV surveillance registry to conduct these analyses. 
Overview of the dissertation 
Overall goals 
I investigated the effect of individual, health care facility, and neighborhood characteristics on the 




and older who were diagnosed with HIV between 2006 and 2012.  The results may be used to improve 
public health by identifying groups of persons with lower rates of achievement or maintenance of viral 
suppression who might benefit from interventions to improve ART initiation and adherence. 
Specific aims 
The following specific aims were addressed: 
AIM 1: Examine the independent effects of individual-, neighborhood- and health care facility-level 
characteristics on HIV viral suppression, among adults and adolescents in New York City who were newly 
diagnosed with HIV between 2006 and 2010.   
AIM 2: Examine the independent effects of individual-, neighborhood- and health care facility-level 
characteristics on HIV virologic failure, among adults and adolescents in New York City who were newly 
diagnosed with HIV between 2006 and 2010. 
AIM 3 (exploratory aim): Examine the independent effect of perceived neighborhood social cohesion on 
HIV viral suppression, among adults in New York City who were newly diagnosed with HIV between 2006 
and 2012. 
Organization of the dissertation 
Following this introduction, the dissertation contains four additional chapters. Chapter 2 assesses 
the individual, facility, and neighborhood factors associated with achievement of viral suppression after 
diagnosis among New Yorkers newly diagnosed with HIV in 2006-2010 (Aim 1).  Chapter 3 begins with 
the subset of persons from the previous aim who achieved viral suppression and assesses the individual, 
facility, and neighborhood factors associated with maintenance of viral suppression (Aim 2). Chapter 4 
assesses individual and neighborhood factors, including perceived neighborhood social cohesion, 
associated with achievement of viral suppression after diagnosis, among a sample of New Yorkers newly 
diagnosed with HIV in 2006-2012 (Aim 3). Chapter 5 summarizes findings from aims 1-3 and discusses 






In this dissertation, I used individual-level data from the NYC HIV surveillance registry and Case 
Surveillance-Based Sampling,[53] facility-level data from the registry, and Census-tract- and ZIP-code-
level data from the 2010 US Census[54] and the 2011 American Community Survey.[55]  The 
surveillance registry includes all persons diagnosed with HIV and reported in NYC since 2000 and all 
persons with AIDS since 1981.  It gathers information by medical record review, provider report at 
diagnosis, personal interviews with patients, and HIV-related laboratory tests, which are electronically 
reported to surveillance for all newly confirmed and existing cases.  With respect to first HIV/AIDS 
diagnosis date, the concordance of surveillance data with medical records is high (84% of NYC AIDS 
patients identified via medical record had been reported to the surveillance registry) and with self-report 
somewhat high (56% of US HIV surveillance-self-report pairs had the same year of diagnosis, and 30% of 
self-reported dates were an earlier year).[56-58]  Surveillance data are also timely, with reportable events 
typically confirmed and appearing in the registry within several months.[57] 
The surveillance registry includes individual-level demographic and clinical information collected 
at the time of first report of HIV diagnosis (Aims 1 and 3) or first VL test indicating suppression (Aim 2), 
address of residence at diagnosis, and HIV-related laboratory test results from 2006-2012 for all New 
Yorkers newly diagnosed with HIV.  Laboratory reports contain the test type, specimen collection date, 
result, and submitting provider or facility.  Health care facility data from 2006-2012 were obtained from the 
registry and linked to cases according to the facility diagnosing the patient (Aims 1 and 3) or that 
conducted the first VL test indicating suppression for each case (Aim 2).  Finally, neighborhood data were 
acquired from the 2010 US Census and the 2011 American Community Survey 5-year estimates.  Place 
of residence was geocoded, and neighborhood data was linked to cases through patient residence at the 
Census tract level (Aims 1 and 2) or ZIP code level (Aim 3).  Case Surveillance-Based Sampling was 
used for Aim 3, including the main questionnaire of the project and three local, scaled questions about 
whether people in the patient’s neighborhood of residence were trustworthy, close-knit, or willing to help 
neighbors.  Answers to these three questions were combined to create a composite measure of 





The outcomes of interest were first viral suppression after diagnosis (Aims 1 and 3) and failure 
after first suppression (Aim 2).  The cut-off for suppression in all three aims was 400 copies/mL because 
this was the highest (i.e., least-sensitive) lower detectable limit of all VL assays used during the study 
period.[59]  In Aim 2, virologic failure was defined as having a VL ≥1,000 copies/mL or not having any VL 
test for 12 consecutive months.  The 1,000-copy cutoff permitted a temporary blip that would not 
necessarily signal virologic failure since VL changes easily,[60] and risk of HIV transmission from a 
person with a VL under 1,000 copies/mL is almost nonexistent.[8, 61]  Requiring VL tests every 12 
months in order to be considered as maintaining suppression ensured at least minimal engagement in 
care and provided an endpoint for persons who dropped out of care, since care was required to detect 
any VL and it was unreasonable to assume that persons who dropped out of care in NYC would remain 
suppressed.  The follow-up period for Aims 1 and 2 ended on 12/31/2012 and for Aim 3 on 6/30/2014. 
Study population 
Our analysis population was drawn from NYC residents who were newly diagnosed with HIV 
between 2006 and 2010 (Aims 1 and 2) or between 2006 and 2012 (Aim 3) and were at least 13 or 18 
years of age at diagnosis (Aims 1 and 3, respectively) or at least 13 at suppression (Aim 2).  Aim 2 was 
limited to the subset of these persons who achieved viral suppression (≤400 copies/mL) ≥31 days 
following diagnosis and by 12/31/2012.  Aim 3 assessed viral suppression for a much smaller population 
(hence its exploratory nature), because it drew from a survey of persons sampled from new diagnoses 
through 2012.  These persons’ addresses were not geocoded to XY coordinates, so neighborhood-level 
variables were constructed at the level of ZIP code. 
Persons were excluded from the analysis population if their death date appeared to precede their 
first diagnosis (Aims 1 and 3) or suppression date (Aim 2), their date of HIV diagnosis or viral suppression 
was potentially misclassified, information about address or neighborhood of residence and facility of 
diagnosis or suppression was missing, or their address data indicated that they were homeless or 
institutionalized.  These exclusions yielded an analytic sample of 12,547 persons in Aim 1, 8,927 persons 





Descriptive statistics were calculated for selected characteristics at the individual, health care 
facility, and neighborhood levels and presented for the overall population and according to viral 
suppression status (Aims 1 and 3) or virologic failure status (Aim 2) within 12 months of diagnosis.  The 
association between each variable and virologic suppression or failure within 12 months was estimated 
using Chi-square statistics; differences in median days to suppression or failure were assessed using the 
Mann-Whitney U test.  
Kaplan-Meier curves showing the number of days from diagnosis to suppression (Aims 1 and 3) 
or suppression to failure (Aim 2) were generated for key individual, health care facility, and neighborhood 
characteristics; log-rank tests were used to assess differences between groups. 
Cox proportional hazards regressions estimated the association of individual, facility, and 
neighborhood-level factors with suppression (Aims 1 and 3) or failure (Aim 2) in crude and adjusted 
models.  When the analytic sample was sufficiently large (Aims 1 and 2), these regressions were 
multilevel.  Specifically, robust sandwich estimation of the standard errors was used to account for 
correlations of individual outcomes clustered within either facility or neighborhood (Census tract).[62, 63]  
After estimating unadjusted rates for suppression (Aims 1 and 3) or failure (Aim 2) for each individual, 
facility, and neighborhood characteristic, models were fitted to estimate the hazards of virologic 
suppression or failure for each characteristic, after adjustment for other characteristics.   
Previous epidemiologic studies of viral suppression have often used survival analysis as their 
methodology.[15, 29, 64, 65]  This time-to-event technique is useful for measuring the amount of time 
between HIV diagnosis and first achievement of viral suppression.  It can also be used to measure the 
amount of time that suppression is maintained after it is achieved, i.e., until virologic failure.  Survival 
analysis also permits persons to be in the analysis for only part of the study period, even if they enter it 
after the start date (e.g., they are newly diagnosed with HIV during the follow-up period) or leave before 
the end date (e.g., they are lost to follow-up before they have the outcome of interest).  The multilevel 
models in Aims 1 and 2 permitted examination of the influence of social and structural (i.e., neighborhood 
and facility) factors and of potential mechanisms by which individual factors such as race/ethnicity might 




Applications of findings 
The findings of these analyses may be valuable to agencies planning testing programs, medical 
care for individuals with HIV, and “prevention with positives” programs.  They may also help strengthen 
existing programs, such as the NYC care coordination program and housing services, which appear to be 
working,[66, 67] or help explain why other programs may not be working.  Findings about neighborhood 
characteristics associated with shorter time to suppression and longer maintenance of suppression could 
identify geographic groups of persons in need of additional services.  They might also influence future 
assessments of areas that could benefit from subsidized and/or supportive housing for persons with HIV.  
Health care facility characteristics associated with shorter time to suppression and longer maintenance of 
suppression could be examined for their “best practices” and these practices considered either for scale-
up across facilities or in recommendations of which types of facilities have the potential to provide the 
best care.  Further analyses could assess how populations with long-term detectable VLs could be 
offered greater support via facility- and neighborhood-level changes, or how HIV care and services 
generally could be structured to maximize (a) the linkage of persons with HIV to facilities that have 
successfully helped patients like them achieve and maintain suppression and (b) the housing of persons 
with HIV in neighborhoods or other communities with suppression-supporting characteristics. 
Ethical considerations 
Ethical approval for these analyses was provided by the Institutional Review Boards of Lehman 
College of the City University of New York and of the New York City Department of Health and Mental 
Hygiene.  Maintenance of confidentiality and privacy of person-level information was a top priority 
throughout the research process.  Among other protections, all person-level data were maintained on 
computer servers of the New York City Department of Health and Mental Hygiene and analyzed in the 
Department’s HIV Epidemiology and Field Services Program, which conducts HIV surveillance and has 
numerous facility, technical, electronic, and procedural safeguards to promote security and minimize 
opportunities for breaches.  The doctoral student underwent confidentiality training at the Department, 




Institutional Training Initiative (CITI), and had over 10 years of professional experience working with data 




Chapter 2. Multilevel analysis of individual, health care facility, and neighborhood 
characteristics associated with achievement of HIV viral suppression among 
persons newly diagnosed with HIV in New York City 
Introduction 
New York City (NYC) is home to more than 7% of all persons newly diagnosed with HIV in the 
United States (US) each year.[1, 2]. It is recommended that persons newly diagnosed with HIV have their 
viral load (VL) measured as soon as they begin HIV-related medical care and then at least every six 
months.[3]  Acute HIV infection typically is followed by a very high VL (e.g., >100,000 copies of HIV RNA 
per milliliter of blood) which eventually declines to lower levels that vary by individual.  Further reduction 
of HIV VL to low or undetectable levels (e.g., ≤400 copies/mL) is referred to as viral suppression.  
Although a small percentage of persons (i.e., “elite controllers") is able to achieve suppression without 
treatment, most persons achieve suppression through treatment with antiretroviral therapy (ART).[4]  
Provided that the virus is sensitive to the multi-drug regimen chosen and the person is adherent, 
suppression is achieved quickly (within 24 weeks) and durably.[5, 6] 
Viral suppression not only slows progression of HIV disease [7] but also reduces the likelihood of 
onward sexual transmission.[8]  As few as 20% of PLWHA were thought to be suppressed in the US in 
the early 2000s, while today most estimates exceed 50%;[10-14] in NYC, it was 59% in 2010.[14]  In 
2010, the US National HIV/AIDS Strategy set as a goal a 20% increase by 2015 in the proportion of 
persons in populations most affected by HIV (blacks, Hispanics, and gay and bisexual men) who are 
virally suppressed.[9] 
Although retention in care and ART are the main drivers of viral suppression, more rapid 
achievement of suppression has also been associated with individual-level demographic characteristics 
(e.g., older age,[13, 15, 20] male sex,[21-23] and non-black racial/ethnic category [13, 24-28]), and 
baseline clinical status indicators (e.g, CD4 count and VL[15, 29, 30]). 
Studies focusing on individual-level factors affecting viral suppression may benefit from the 
addition of variables describing characteristics of health care facilities in which people are diagnosed, as 
these characteristics have been shown to influence intermediary health outcomes among persons with 




diagnosis,[35] receipt of ART,[33, 34] and adherence to treatment, all necessary steps toward viral 
suppression.[32]  The type of clinical setting and accessibility of a medical facility including travel distance 
for patients, as well as the support it offers its patients, can affect adherence.[32]  Few studies on viral 
suppression, however, have included these facility characteristics.[31-33] 
Similarly, the relationship between neighborhood-level socioeconomic characteristics and viral 
suppression has rarely been studied.  Lower socioeconomic status has been associated with higher rates 
of diagnosis of HIV or AIDS, delayed access to treatment, and mortality.[31, 33, 38-43]  For example, in a 
US city, HIV-positive residents of higher-unemployment neighborhoods were less likely to be on ART.[43]  
Even in a province of Canada, a country with universal health care and free HIV treatment, after 
controlling for clinical characteristics, it was found that residents of lower-SES neighborhoods (as 
measured by median income) were less likely than residents of higher-SES neighborhoods to be 
prescribed the ART regimen that was the standard of care.[33]  We therefore investigated the effect of 
individual, health care facility, and neighborhood characteristics on achievement of viral suppression, 
among NYC residents ≥13 years of age who were diagnosed with HIV between 2006 and 2010, before 
and after controlling for selected characteristics. 
Methods 
Data sources 
This retrospective analysis used data from the NYC HIV surveillance registry, the 2010 US 
Census,[54] and the 2011 American Community Survey.[55]  The surveillance registry includes all 
persons diagnosed and reported with AIDS in NYC since 1981 and HIV since 2000.  It gathers 
information by medical record review, provider report at diagnosis, personal interviews with patients, and 
HIV-related laboratory tests, which are electronically reported to surveillance for all cases receiving 
diagnosis and/or care in NYC. 
Individual-level data acquired from the registry included demographic and clinical information 
collected at the time of first report, address of residence at diagnosis, and HIV-related laboratory test 
results from 2006-2012 for all New Yorkers diagnosed with HIV.  Laboratory reports contain the test type, 
specimen collection date, result, and submitting provider or facility.  Reports on existing cases are added 




the diagnosis and collect other required data.  Health care facility data from 2006-2012 were obtained 
from the registry and linked to cases according to the facility diagnosing each case with HIV.  All registry 
data used in this analysis were reported as of September 30, 2013.  Finally, neighborhood data at the 
Census tract level were acquired from the 2010 US Census and the 2011 American Community Survey 
5-year estimates.  Neighborhood data were linked to cases through the Census tract of patient residence, 
which was geocoded from address of residence to the 2010 Census tract.  The process of creating an 
analytic dataset with individual, facility, and neighborhood data is described in Appendix 3. 
Population 
NYC residents who were newly diagnosed with HIV between 2006 and 2010 and at least 13 
years of age at diagnosis (N=17,825 persons) were excluded if their address could not be geocoded to 
Census tract (n=2,560), if their facility- or neighborhood-level characteristics were unknown (n=206), if 
their address of residence and of facility of diagnosis were equivalent, possibly indicating a homeless or 
institutionalized person (n=471), if they were diagnosed at a correctional facility (n=252), or if they did not 
survive at least 31 days following diagnosis (n=220).  We further excluded 1,569 persons with neither a 
Western blot confirmatory test within 31 days of diagnosis nor a diagnosis of acute HIV infection (n=716); 
persons with a detectable (>50 copies/mL) viral load >31 days prior to diagnosis (n=1); and persons with 
a suppressed (≤400 copies/mL) viral load <31 days following diagnosis, values that indicate either elite 
controllers or previous use of ART (n=852).  These exclusions yielded an analytical sample of 12,547 
persons (see Appendix 1).  
Outcome 
The outcome of interest was the first suppressed VL (≤400 copies of HIV RNA/mL plasma) after 
HIV diagnosis.  The cut-off was 400 copies/mL because this was the highest lower detectable limit of all 
VL assays in use during the study period.[59]  Persons were censored at death or the end of the follow-up 
period, whichever came earlier.  Follow-up time was calculated as the number of days from the date of 
HIV diagnosis to suppression, death, or 12/31/2012, whichever came first. 
Treatment guidelines evolved during the analysis period but recommended VL tests between 2-4 




tests after diagnosis, because they were never linked to HIV-related medical care, they sought care 
infrequently, or their physician did not test their VL at every care visit.  Persons who were not known to be 
dead and who had no suppressed VL (including persons with infrequent or no VL tests) were presumed 
not to be suppressed and contributed follow-up time as long as they were alive. 
Covariates 
Individual-level variables  
Demographic characteristics (age, sex at birth, race/ethnicity, area of birth), HIV transmission risk 
(also referred to as transmission categories), diagnosis date, viral loads, CD4 counts, and address of 
residence at diagnosis were extracted from the NYC HIV surveillance registry.  Age at HIV diagnosis was 
calculated from birth date and date of diagnosis and categorized as 13-19, 20-29, 30-39, 40-49, 50-59, 
and 60+.[2]  Sex at birth was classified as male or female.  Race was collected as white or Caucasian, 
black or African American, Asian or Pacific Islander, and Native American.  Ethnicity was collected as 
Hispanic, non-Hispanic, or unknown.  Race and ethnicity were combined into a single variable in which all 
persons of Hispanic ethnicity were classified as Hispanic, and non-Hispanics were classified as black, 
white, or other non-Hispanic race (which included Asians and Pacific Islanders, Native Americans, and 
multiracial persons).[15]  Area of birth was collected as country of birth when available or region of birth 
and categorized as born in the US, US dependency (e.g., Puerto Rico), foreign country, or unknown place 
of birth.[68]  HIV transmission risk category was based on the self-reported pre-diagnosis risk behaviors 
of the case (e.g., injection drug use, male-male sex) and the sex, HIV status (e.g., HIV-positive), and risk 
(e.g., injection drug use) of the pre-diagnosis heterosexual-sex partners that s/he reports (which could 
indicate high-risk heterosexual risk).[69]  This information was combined into hierarchical, mutually 
exclusive categories for the case: injection drug use (IDU), men who have sex with men (MSM), 
heterosexual sex, and other or unknown (which included perinatal transmission).[15]  To be classified as 
a heterosexual male or female, persons must have reported pre-diagnosis sex with a partner of the other 
sex who was HIV-infected, had injected drugs, or had received blood products.  In addition, females only 
could be classified as heterosexual if they had probable heterosexual transmission noted in their medical 
record, reported sex with a male and no history of drug injection, or had any one of several behaviors 




transmitted disease, crack/cocaine use, or sex with a bisexual male.[2]  For analytic purposes, the year of 
diagnosis was determined from the earlier of physician diagnosis date or positive Western blot test result 
(2006, 2007, 2008, 2009, 2010).  CD4 count (if any) at diagnosis (i.e., within 3 months of diagnosis) and 
year of diagnosis vis-à-vis treatment guidelines were used to estimate treatment eligibility and as a proxy 
for receipt of ART, on the presumption that the majority of persons reaching the federal treatment 
threshold would be offered and receiving ART.  Treatment-eligible persons included those diagnosed in 
2006-2007 and with CD4<200, diagnosed in 2008-2009 and with CD4<350, or diagnosed in 2010 and 
with CD4<500, reflecting changing treatment guidelines that increased the CD4 count at which ART 
initiation was recommended.[70-72]  All other persons, including those with no reported CD4 counts, were 
not known to be eligible and were classified as not eligible. 
Health care facility-level variables 
Facility-level characteristics include annual HIV patient volume, facility type, and patient-facility 
distance. HIV patient volume was collected as number of new HIV diagnoses made annually, based on 
diagnoses attributed by surveillance to that facility in the year of the patient’s diagnosis, and categorized 
as <10, 10-24, 25-49, 50-74, and ≥75 diagnoses per year.[33, 73]  Facility type was categorized as 
inpatient/hospital, private provider, other outpatient facility, screening/diagnosis/referral facility, and other 
or unknown (<10 persons had a known facility but unknown type), as potential indicators of the availability 
of colocated care (at the first three facility types) [35] and ancillary services (at the first and third types) 
[32].  Patient-facility distance was calculated as the distance in miles along NYC streets from patient 
residence to the facility of diagnosis (based on the XY coordinates of each) using Network Analyst in 
ArcMap 10.0 (ESRI, Redmonds, CA) (see Appendix 4).  This distance was categorized as <1 mile, 1-<5 
miles, 5-<10 miles, and ≥10 miles. 
Neighborhood-level variables 
Analyses included two Census tract-level SES measures from 2011 American Community Survey 
(ACS) 5-year estimates, which is the recommended source for such statistics because the 2010 
decennial census did not collect them.[74]  These measures, which previously have been associated with 
HIV or sexually transmitted infections or HIV outcomes, were percent of residents with incomes under 




41, 75]  Census 2010 provided data on percent of non-Hispanic black residents, as it is the recommended 
data source for population race/ethnicity statistics. [74]  The values for percent unemployed and percent 
black were divided by 10 and entered into a proportional hazards regression as continuous variables; 
measures of association would therefore be for 10-percentage-point differences.  Poverty was 
categorized as 0 to <10% (low-poverty), 10 to <20% (medium-poverty), 20 to <30% (high-poverty), and 
30 to 100% (very-high-poverty), based on recommendations of the NYC health department.[76]  This 
particular set of three neighborhood-level variables (poverty, unemployment, and percent black) has been 
used previously.[43] 
Statistical analysis 
Descriptive statistics were calculated for selected characteristics at the individual, health care 
facility, and neighborhood levels and presented for the overall population and according to suppression 
status within 12 months (365 days) of diagnosis.  The association between each variable and 
achievement of suppression within 12 months was measured using Chi-square tests.  The Mann-Whitney 
U test was used to ascertain differences in median days to suppression by the end of the follow-up 
period. 
Kaplan-Meier curves showing the number of days from diagnosis to suppression were generated 
by key individual and health care facility characteristics, and log-rank tests were used to indicate 
differences between groups. 
We used Cox proportional hazards regressions to estimate the association of individual, facility, 
and neighborhood-level factors with suppression in crude and adjusted models.  Robust sandwich 
estimation of the standard errors was used to account for correlations of individual outcomes clustered 
within either facility of diagnosis or neighborhood (Census tract).[62, 63]  Unadjusted models were fitted 
to estimate the unadjusted hazards of viral suppression for each individual, facility, and neighborhood 
characteristic. In addition, several models were fitted.  First, hazards of viral suppression for each 
individual characteristic were estimated after adjustment for all other individual characteristics.  Second, 
models were fitted to estimate the hazards for each facility and each neighborhood characteristic, after 
controlling for individual characteristics.  Finally, two models were fitted to estimate the adjusted hazards 




All analyses were conducted using SAS 9.2 (SAS Institute, Cary, NC).  Ethical approval for these 
analyses was provided by the Institutional Review Boards of Lehman College of the City University of 
New York and of the NYC Department of Health and Mental Hygiene. 
Results 
Descriptive statistics 
Of 12,547 New Yorkers newly diagnosed with HIV in 2006–2010, approximately three-quarters 
were 20-49 years old (78.7%), male (74.2%), and black or Hispanic (81.5%; Table 2.1).  In addition, 
approximately half were US-born (53.5%) and MSM (44.5%), and about one-third were eligible to receive 
treatment based on CD4 and diagnosis year (30.6%).  Forty-four percent of the population achieved 
suppression within 12 months of diagnosis.  Those who did not suppress within 12 months were more 
likely to be younger, black, US-born, MSM or IDU, diagnosed in earlier years, and not eligible for 
treatment. 
Almost three-quarters of the population (72.8%) achieved viral suppression by 12/31/2012 (not 
shown), in a median of 245 days (Table 2.1).  Suppression happened least quickly among persons who 
were younger, diagnosed in earlier years, and not known to be eligible for treatment; differences were 
most prominent by treatment eligibility (127 days among eligible vs. 415 days among not eligible), 
differences also demonstrated in Kaplan-Meier survival curves (p<0.0001; Figure 2.1a). 
Approximately half of the population was diagnosed in facilities that diagnosed 10-74 persons 
(45.0%), were hospitals (42.7%), and were 1 to <5 miles from their home (51.0%; Table 2.2); and lived in 
neighborhoods where ≥20% of the population was below the poverty threshold (i.e., high or very high 
poverty; 58.0%).  Neighborhoods where people lived had a mean unemployment rate of 10.8%, and black 
persons comprised a mean of 34.3% of the population. 
When compared to persons achieving suppression within 12 months of diagnosis, those who did 
not achieve it were more likely to be diagnosed at facilities that diagnosed fewer persons with HIV, were 
screening or outpatient facilities, and were ≥10 miles from the patient’s residence (Table 2.2); differences 
in suppression by the first two characteristics were also visible in Kaplan-Meier survival curves (Figures 
2.1b and 2.1c).  Suppression happened least quickly among persons diagnosed at non-hospital facilities 




Modelling individual characteristics 
Table 2.3 presents the unadjusted and adjusted HRs for individual characteristics on HIV viral 
suppression among persons newly diagnosed with HIV in NYC.  The unadjusted HRs show that persons 
who were younger, male, black, US-born or MSM were at least 7% less likely to achieve viral suppression 
(range 7% to 43%).  The same decrement applied to those diagnosed before 2010 and those who were 
not treatment-eligible. 
After adjusting for individual characteristics, the likelihood of viral suppression was 16-29% lower 
for persons 13-49 years old relative to those 60 and older (e.g., 20-29 years old, 24%[95%CI=0.67-0.86]) 
and 10% (95%CI=0.83-0.97) lower among men than women.  Blacks and Hispanics were 19% 
(95%CI=0.76-0.86) and 12% (95%CI=0.82-0.94) less likely to suppress than their white counterparts.  
US-born persons were 8% (95%CI=0.87-0.97) less likely to suppression than foreign-born, and persons 
diagnosed in 2006 and 2008 were at least 11% (e.g., 2006, 11%[95%CI=0.83-0.96]) less likely to 
suppress than persons diagnosed in 2010.  Compared with heterosexuals, MSM went from being less 
likely (in crude models) to as or more likely (in models adjusting for other individual characteristics) to 
suppress (AHR[95%CI]=1.08[1.00-1.17]).  Finally, persons not eligible for treatment were 65% less likely 
than treatment-eligible persons to suppress, presumably because treatment-eligible persons were more 
likely to have been prescribed ART, almost the exclusive means of lowering viral load.  These findings 
remained nearly identical when adjusting for either facility or neighborhood characteristics (AHRs 2 and 3 
in Table 2.3). 
Modelling facility and neighborhood characteristics 
Table 2.4 presents the unadjusted and adjusted HRs for facility and neighborhood characteristics 
on HIV viral suppression among persons newly diagnosed with HIV in NYC.  The unadjusted HRs show 
that persons diagnosed at facilities diagnosing <10 patients per year or that were a type other than a 
hospital were at least 10% less likely to achieve viral suppression (range 10% to 38%; e.g., outpatient 
facilities, 25% [95%CI=0.71-0.79]).  At facilities 1 to <5 miles from the patient vs. <1 mile, 8% more likely 
(95%CI=1.02-1.14).  Although marginally significant, each 10% increase in the proportion of 
neighborhood residents that was unemployed or black was associated with, respectively, a 5% 




After adjusting for individual characteristics alone, and then individual characteristics as well as 
either facility or neighborhood characteristics, facility-related findings remained similar as in the bivariate 
models, with the exception of persons diagnosed at private physicians becoming more likely to achieve 
suppression (when controlling for both individual and facility characteristics, AHR[95%CI]=1.08[0.95-
1.22]).  The model with all individual- and facility-level variables had the best fit (-2LL: 158,585; p<0.0001 
vs. the model with all individual-level variables only; see Appendix 5).  Neighborhood characteristics were 
no longer associated with suppression in models adjusted for individual characteristics. 
Discussion 
Controlling for individual and facility characteristics, persons who were younger, male, non-white, 
US-born, non-MSM, diagnosed in earlier years, and not eligible for treatment took longer to achieve HIV 
viral suppression after diagnosis.  Persons diagnosed at facilities that diagnosed relatively few patients or 
that were screening, diagnosis, and referral sites also took longer to suppress.  Neighborhood-level 
characteristics did not influence the time from diagnosis to viral suppression. 
Our findings about individual and facility characteristics were consistent with the literature.  
Individual-level factors associated with suppression were similar to a previous study using NYC HIV 
surveillance data.[15]  After adjustment for other individual characteristics, MSM went from having slower 
suppression than heterosexuals to as quickly or quicker.  One possible explanation is that newly 
diagnosed MSM were younger, healthier, and less likely to be eligible for ART than heterosexuals, but 
compared with heterosexuals, MSM had equivalent or better treatment access generally and/or 
adherence once on ART.  However, our findings provided unique information about teenagers, who have 
been included in few prior analyses of viral suppression.  Our analysis found teenagers to have, relative 
to persons ≥60 years old, similarly reduced rates of suppression as persons in their 20s.  Teenagers are 
known to face challenges linking to care after diagnosis, being retained in care, and adhering to ART to 
achieve suppression;[77, 78] these age-related disparities are not entirely attributable to teenagers being 
in an earlier stage of disease than older persons.  Persons diagnosed at facilities that diagnosed fewer 
patients or that only screened, diagnosed, and referred patients had lower rates of suppression than 
persons diagnosed elsewhere.  It is possible that these facilities were less likely to provide on-site HIV-




shown to facilitate linkage after diagnosis[35] and retention in care;[79, 80] or because their providers are 
less likely to adhere to HIV-related care recommendations.[81] 
Findings about neighborhood characteristics were not consistent with the scant literature on their 
relationship with HIV outcomes.  While neighborhood-level socioeconomic factors have been associated 
with HIV diagnosis rates in NYC and elsewhere, and some care-related outcomes,[31, 33, 38-42] in our 
analysis, neighborhood characteristics were not associated with time to suppression once diagnosed.  
Several possible explanations include different outcomes (e.g., time from ART initiation to suppression vs. 
time from diagnosis to suppression) and different settings (e.g., Canada vs. US, or other US areas vs. 
NYC).  Accessible, effective HIV care is perhaps available regardless of characteristics of the NYC 
neighborhood in which people live, mitigating neighborhood-level disadvantage after diagnosis.  Finally, 
publication bias may have limited the publication of previous null findings on neighborhood characteristics 
and HIV outcomes.[82, 83] 
Being diagnosed at a facility 1 to <5 miles from one’s residence was also associated with quicker 
suppression relative to ≥10 miles away, suggesting that proximity may be important, although interestingly 
persons diagnosed at facilities within one mile of their residences did not share this advantage.  These 
were not known to be institutionalized persons, who were excluded from the analysis because their 
outcomes might be influenced by neighborhood and facility differently than non-institutionalized persons.  
Rather, perhaps facilities <1 mile from persons’ residences were disproportionately (a) offices of their 
regular (i.e., pre-HIV-infection) primary care physicians and/or (b) selected for convenience.  In either 
case, staff may have had less expertise in managing HIV or making effective linkages to HIV specialty 
care.  This hypothesis is feasible if these factors are independent from patient volume and facility type, 
which were controlled for.  Unfortunately, we did not know the mode of transportation nor time required to 
get to the facility, which may at least partially explain why persons <1 mile from their facilities did not 
experience quickest suppression.  An analysis on correlates of the distance that persons with HIV in 
another Northeast US city, Philadelphia, travel for care found that greater patient distance from the 
nearest care site was associated with non-achievement of viral suppression, among persons who had 
been retained.[84]  However, distance was not associated with progression along other parts of the 




analyses (where ours followed persons from diagnosis to suppression and theirs from retention to 
suppression) may account for the different findings. 
Limitations 
As in any population-based analysis of HIV care, ours had VL data only when persons sought 
care, which was at their discretion.  Persons in this analysis were not necessarily tested at regular 
intervals and may have achieved suppression sometime before it was measured in a VL test.  It is not 
clear whether these circumstances would have over- or underestimated our hazard ratios.  However, 
most persons in the analysis (88%) had at least one VL test between 8 days post-diagnosis and death 
(Appendix 6).  Among that 88%, persons diagnosed in 2006, with the most follow-up, had a median of 17 
VL tests (IQR: 10-23) and the median interval between tests was 120 days (4 months; IQR: 95-182 days), 
while persons diagnosed in 2010 had a median of 8 tests (IQR: 5-10) and the median interval between 
tests was 101 days (3 months; IQR: 85-139 days).  These estimates indicate that the majority of New 
Yorkers newly diagnosed with HIV between 2006 and 2010 were engaged in care at intervals that were 
both consistent with federal guidelines and sufficiently frequent to produce population-level estimates of 
suppression. 
Persons not in care in NYC were presumed to be present and unsuppressed, although they may 
have moved out of NYC and become suppressed elsewhere.  Non-ascertainment of outmigration is a 
typical limitation of local HIV surveillance data.  An analysis of mobility among NYC AIDS cases who died 
found that males, whites, MSM, and younger persons were more likely to have left the city;[85] it is 
possible that the same demographic and risk groups are more likely to leave NYC shortly after HIV 
diagnosis and thus have undetected suppression.  All of these circumstances increase the apparent time 
to suppression overall, and higher outmigration in some groups could result in differential 
underascertainment of suppression.  This may have overestimated the male-female disparity in 
suppression rates (i.e., made the HR for males lower) but underestimated disparities by race/ethnicity and 
risk (i.e., decreased the HRs for white and MSM), since whites and MSM were most likely, in multivariable 
models, to achieve suppression. 
We note that a newly diagnosed person who is in NYC but not in care and not getting blood 




as such, there is likely little underascertainment of suppression among persons actually in NYC.  
Additionally, newly diagnosed persons were known to be in NYC as recently as their diagnoses, if not at 
later points of care, and thus have had relatively little time to leave NYC.  Further, the system of care and 
services, comparatively generous benefits, and large HIV-positive population in NYC make it a relatively 
attractive place for HIV-positive persons to live and receive care. 
There are several steps between diagnosis and suppression in the continuum of care for HIV-
positive persons.[10, 13]  By design, this analysis did not elucidate the exact step(s) at which facility-level 
factors affect suppression.  Other analyses have investigated the role of facility or health care services in 
intermediate steps in the continuum, such as time from diagnosis to linkage,[35, 86] continuous care or 
retention in care,[79, 80, 87] and ART use and suppression among persons in care.[88] 
Characteristics measured at one level may have acted at another level.  For example, poverty 
was measured at the neighborhood level only and was found not to be significantly associated with 
suppression.  It is possible that there is no association between individual-level poverty, which we could 
not measure, and suppression, or alternatively, that individual-level poverty would in fact have been 
associated with suppression.  This limitation is not unique to our analysis but rather is a characteristic 
shortcoming of multilevel analyses.[89, 90] 
Strengths 
This is among the first analyses in the US to investigate the influence of facility and neighborhood 
on HIV outcomes using surveillance data. [31, 33, 35, 87]  The data were drawn from population 
surveillance in the largest HIV epidemic in the US, in a diverse US city.  It combined data from multiple 
sources to assess the potential influence on viral suppression of factors beyond the individual.  
Mandatory electronic reporting of laboratory tests in NYC provided information about all measured VLs for 
all HIV-positive persons receiving care in NYC, as opposed to in a clinical trials environment, where 
findings can differ from those in a population setting.  We filled a gap in the literature by including 
teenagers, who are subject to the same treatment guidelines as adults but whose young age may have 
contributed to slower suppression than among older persons.[78]  To assign area-based characteristics to 




detection of public health disparities;[47] other geographic analyses of HIV care outcomes have used only 
counties and ZIP codes, which are much larger than Census tracts. 
Conclusions 
We have identified individual and facility characteristics that seem to help persons newly 
diagnosed with HIV to achieve viral suppression, thus improving their health and preventing ongoing HIV 
transmission.  Those persons or health care facilities with characteristics associated with slower 
achievement of suppression may need more assistance after diagnosis with linkage to and retention in 
care or ART prescribing and adherence.  For example, black persons may benefit from more-frequent 
medical care and prescription of ART that permits them to become suppressed at comparable rates as 
whites;[15, 22, 25-27, 91] rectifying this disparity may require more equitable prescribing behavior and/or 
better adherence support.[92]  NYC can continue to encourage HIV testing at large facilities, including 
hospitals, where patients have the greatest likelihood of reaching suppression quickly.  We can also 
increase the capacity of facilities that make fewer diagnoses annually, or that are neither hospitals nor 
private physicians’ offices, to move their patients along the continuum of care from diagnosis to 
suppression, even if this means ensuring effective linkage to care at another site that has cared for more 
HIV-positive patients.  Since 2010, New York State law has required all providers to link positive patients 
to care, and the United States Department of Health and Human Services now encourages antiretroviral 
therapy for all diagnosed persons, regardless of CD4 count, which should further the improvement in 
suppression rates.  Future studies should monitor whether facility-level disparities in suppression 






Table 2.1. Achievement of HIV viral suppression among persons newly diagnosed with HIV in New York City in 2006-2010 
and followed through 2012, by individual-level characteristics 





months   
Virologically suppressed within 12 
months   
Median time from 
diagnosis to 
suppression 




Total 100.0 (12,547)   100.0 (7,031)   100.0 (5,516) 44.0     245 (532)   
Age group (years) at diagnosis        <0.0001    <0.0001 
13 – 19 4.7 (590)  5.8 (405)  3.4 (185) 31.4   436 (772)   
20 – 29 27.9 (3,497)  30.9 (2,172)  24.0 (1,325) 37.9   339 (633)   
30 – 39 26.2 (3,290)  26.6 (1,868)  25.8 (1,422) 43.2   255 (551)   
40 – 49 24.6 (3,087)  23.1 (1,627)  26.5 (1,460) 47.3   210 (453)   
50 – 59 12.0 (1,502)  10.0 (701)  14.5 (801) 53.3   178 (334)   
≥60 4.6 (581)  3.7 (258)  5.9 (323) 55.6   150 (228)   
Sex at birth       0.0009    <0.0001 
Male 74.2 (9,309)  75.3 (5,297)  72.7 (4,012) 43.1   263 (550)   
Female 25.8 (3,238)  24.7 (1,734)  27.3 (1,504) 46.4   206 (463)   
Race/Ethnicity       0.0009   0.0003 
Black 49.1 (6,162)  50.5 (3,552)  47.3 (2,610) 42.4   236 (533)   
Hispanic 32.3 (4,058)  31.6 (2,223)  33.3 (1,835) 45.2   248 (515)   
White 15.2 (1,912)  14.9 (1,049)  15.6 (863) 45.1   285 (568)   
Other 3.3 (415)  2.9 (207)  3.8 (208) 50.1   186 (367)   
Country of birth        <0.0001    <0.0001 
US 53.5 (6,713)  56.9 (4,002)  49.1 (2,711) 40.4   291 (592)   
US Dependency 4.5 (565)  4.4 (312)  4.6 (253) 44.8   234 (475)   






Unknown 10.5 (1,318)  11.0 (770)  9.9 (548) 41.6   263 (566)   
HIV transmission risk        <0.0001    <0.0001 
Men who have sex with men 44.5 (5,580)  46.0 (3,236)  42.5 (2,344) 42.0   304 (606)   
Injection drug use history 5.2 (653)  5.4 (380)  4.9 (273) 41.8   273 (524)   
Heterosexual 25.5 (3,198)  23.8 (1,672)  27.7 (1,526) 47.7   206 (461)   
Other or unknown 24.8 (3,116)  24.8 (1,743)  24.9 (1,373) 44.1   202 (440)   
Year of HIV diagnosis        <0.0001    <0.0001 
2006 20.5 (2,570)  22.6 (1,587)  17.8 (983) 38.2   363 (935)   
2007 20.5 (2,569)  22.2 (1,559)  18.3 (1,010) 39.3   326 (661)   
2008 21.0 (2,641)  21.3 (1,496)  20.8 (1,145) 43.4   245 (550)   
2009 19.8 (2,486)  18.8 (1,320)  21.1 (1,166) 46.9   211 (380)   
2010 18.2 (2,281)  15.2 (1,069)  22.0 (1,212) 53.1   170 (255)   
Eligible for treatment        <0.0001    <0.0001 
Yes 30.6 (3,834)  14.5 (1,016)  51.1 (2,818) 73.5   127 (141)   
No 69.4 (8,713)   85.5 (6,015)   48.9 (2,698) 31.0     415 (708)   
                      
1 p-value: Chi-square test of association between each variable and achievement of suppression 
2 IQR: Interquartile range, i.e., 3rd quartile minus 1st quartile 







Table 2.2. Achievement of HIV viral suppression among persons newly diagnosed with HIV in New York City in 2006-2010 
and followed through 2012, by characteristics of the health care facility at which persons were diagnosed and the 
neighborhood (Census tract) persons were living in at diagnosis 






Virologically suppressed within 12 
months   





(n) or Mean 






Total 100.0 (12,547)   100.0 (7,031)   100.0 (5,516) 44.0     245 (532)   
Facility-level variables            
Number of HIV diagnoses made 
annually by health care facility 
that diagnosed patient 
      0.0007   0.1165 
<10 33.2 (4,169)  34.1 (2,396)  32.1 (1,773) 42.5   256 (566)   
10 to 24 13.9 (1,741)  13.9 (974)  13.9 (767) 44.1   235 (454)   
25 to 49 16.5 (2,073)  17.2 (1,208)  15.7 (865) 41.7   265 (582)   
50 to 74 14.6 (1,828)  14.3 (1,004)  14.9 (824) 45.1   219 (486)   
≥75 21.8 (2,736)  20.6 (1,449)  23.3 (1,287) 47.0   245 (507)   
Type of facility that diagnosed 
patient 
       <0.0001   <0.0001 
Hospital 42.7 (5,358)  37.9 (2,668)  48.8 (2,690) 50.2   195 (405)   
Outpatient 22.8 (2,865)  25.2 (1,769)  19.9 (1,096) 38.3   315 (606)   
Private physician 18.6 (2,332)  18.2 (1,283)  19.0 (1,049) 45.0   261 (567)   
Screening/diagnosis/referral 13.9 (1,743)  16.3 (1,148)  10.8 (595) 34.1   350 (636)   
Other or unknown 2.0 (249)  2.3 (163)  1.6 (86) 34.5   253 (573)   
Distance between patient and 
facility 






<1 mile 21.4 (2,683)  22.3 (1,569)  20.2 (1,114) 41.5   266 (579)   
1 to <5 miles 51.0 (6,398)  49.1 (3,452)  53.4 (2,946) 46.0   225 (495)   
5 to <10 miles 20.0 (2,509)  20.3 (1,428)  19.6 (1,081) 43.1   273 (524)   
≥10 miles 7.6 (957)  8.3 (582)  6.8 (375) 39.2   280 (568)   
Neighborhood-level variables            
Percent of population below 
federal poverty threshold in past 
12 months 
      0.0304   0.1715 
Low (<10%) 15.9 (1,992)  15.4 (1,081)  16.5 (911) 45.7   228 (482)   
Medium (10 to <20%) 26.1 (3,280)  25.9 (1,821)  26.5 (1,459) 44.5   245 (517)   
High (20 to <30%) 25.1 (3,153)  24.8 (1,745)  25.5 (1,408) 44.7   234 (515)   
Very high (≥30%) 32.9 (4,122)  33.9 (2,384)  31.5 (1,738) 42.2   267 (571)   
Unemployment rate among 
population 16 years and over 
10.8 (5.6)  -  - - N/A  - N/A 
Percent of population that is 
black or African American only 
(non-Hispanic) 
34.3 (29.2)  -  - - N/A  - N/A 
                      
1 p-value: Chi-square test of association between each variable and achievement of suppression    
2 IQR: Interquartile range, i.e., 3rd quartile minus 1st quartile    







Table 2.3. Proportional hazards regressions of HIV viral suppression among persons newly diagnosed with HIV in New 
York City in 2006-2010 and followed through 2012, by individual-level characteristics 
   
HR                                 
(95% CI)1  
AHR 1                      
(95% CI)1,2  
AHR 2                         
(95% CI)1,3  
AHR 3                          
(95% CI)1,4 
Age group (years) at diagnosis                 
13 - 19  0.57 (0.49-0.65)  0.71 (0.61-0.83)  0.75 (0.64-0.86)  0.71 (0.61-0.83) 
20 - 29  0.64 (0.57-0.72)  0.76 (0.67-0.86)  0.79 (0.69-0.90)  0.76 (0.67-0.86) 
30 - 39  0.69 (0.61-0.77)  0.78 (0.69-0.88)  0.80 (0.71-0.90)  0.78 (0.69-0.88) 
40 - 49  0.76 (0.67-0.85)  0.84 (0.74-0.94)  0.85 (0.76-0.95)  0.84 (0.74-0.94) 
50 - 59  0.88 (0.78-1.00)  0.94 (0.83-1.06)  0.95 (0.84-1.08)  0.94 (0.83-1.06) 
≥60  1.00  1.00  1.00  1.00 
Sex at birth          
Male  0.93 (0.89-0.97)  0.90 (0.83-0.97)  0.90 (0.83-0.97)  0.89 (0.83-0.97) 
Female  1.00  1.00  1.00  1.00 
Race/Ethnicity          
Black  0.83 (0.78-0.88)  0.81 (0.76-0.86)  0.84 (0.79-0.90)  0.81 (0.75-0.87) 
Hispanic  0.94 (0.88-1.00)  0.88 (0.82-0.94)  0.91 (0.85-0.98)  0.87 (0.81-0.94) 
White  1.00  1.00  1.00  1.00 
Other  1.03 (0.90-1.18)  0.89 (0.77-1.03)  0.91 (0.79-1.05)  0.89 (0.77-1.03) 
Country of birth          
US  0.84 (0.81-0.88)  0.92 (0.87-0.97)  0.92 (0.87-0.98)  0.92 (0.87-0.97) 
US Dependency  0.95 (0.86-1.06)  0.98 (0.88-1.10)  0.99 (0.88-1.10)  0.98 (0.88-1.10) 
Foreign  1.00  1.00  1.00  1.00 
Unknown  0.80 (0.74-0.86)  0.88 (0.81-0.95)  0.87 (0.79-0.95)  0.88 (0.81-0.95) 
HIV transmission risk          
Men who have sex with men  0.93 (0.88-0.97)  1.08 (1.00-1.17)  1.11 (1.02-1.19)  1.09 (1.00-1.18) 
Injection drug use history  0.87 (0.79-0.96)  0.92 (0.82-1.02)  0.93 (0.84-1.04)  0.92 (0.82-1.02) 






Other or unknown  0.83 (0.78-0.88)  0.86 (0.79-0.93)  0.86 (0.79-0.93)  0.86 (0.79-0.93) 
Year of HIV diagnosis          
2006  0.67 (0.63-0.72)  0.89 (0.83-0.96)  0.87 (0.81-0.95)  0.89 (0.83-0.95) 
2007  0.71 (0.67-0.76)  0.94 (0.87-1.01)  0.92 (0.85-1.00)  0.94 (0.87-1.01) 
2008  0.74 (0.70-0.80)  0.87 (0.81-0.93)  0.86 (0.79-0.93)  0.87 (0.81-0.93) 
2009  0.84 (0.79-0.90)  1.02 (0.95-1.10)  1.02 (0.95-1.10)  1.02 (0.95-1.10) 
2010  1.00  1.00  1.00  1.00 
Eligible for treatment          
Yes  1.00  1.00  1.00  1.00 
No   0.34 (0.32-0.36)   0.35 (0.33-0.37)   0.36 (0.34-0.38)   0.35 (0.33-0.37) 
1 Hazard ratios and confidence intervals for models with only individual- or neighborhood-level variables account for clustering by Census tract, and those 
with facility-level variables account for clustering by facility of diagnosis.  Hazard ratios (HR) are unadjusted unless indicated as “AHR.” 
2 Adjusted hazard ratio 1: For each individual-level variable, adjusting for all other individual-level variables 
3 Adjusted hazard ratio 2: For all individual-level variables, adjusting for all facility-level variables 






Table 2.4. Proportional hazards regressions of HIV viral suppression among persons newly diagnosed with HIV in New 
York City in 2006-2010 and followed through 2012, by characteristics of the health care facility at which persons were 
diagnosed and the neighborhood (Census tract) persons were living in at diagnosis 
   
HR                                 
(95% CI)1  
AHR 1                      
(95% CI)1,2  
AHR 2                         
(95% CI)1,3  
AHR 3                          
(95% CI)1,4 
Facility-level variables                 
Number of HIV diagnoses made annually by 
health care facility that diagnosed patient 
         
<10  0.85 (0.80-0.90)  0.93 (0.85-1.01)  0.90 (0.81-1.01)    
10 to 24  0.82 (0.77-0.88)  0.85 (0.76-0.95)  0.87 (0.79-0.95)    
25 to 49  0.83 (0.78-0.89)  0.85 (0.77-0.93)  0.85 (0.78-0.92)    
50 to 74  0.87 (0.81-0.93)  0.88 (0.81-0.95)  0.87 (0.80-0.94)    
≥75  1.00  1.00  1.00    
Type of facility that diagnosed patient          
Hospital  1.00  1.00  1.00    
Outpatient  0.75 (0.71-0.79)  0.91 (0.86-0.96)  0.93 (0.84-1.02)    
Private physician  0.90 (0.85-0.95)  1.05 (0.99-1.11)  1.08 (0.95-1.22)    
Screening/diagnosis/referral  0.65 (0.61-0.70)  0.84 (0.78-0.90)  0.86 (0.80-0.92)    
Other or unknown  0.62 (0.53-0.73)  0.78 (0.66-0.92)  0.80 (0.62-1.02)    
Distance between patient and facility          
<1 mile  1.00  1.00  1.00    
1 to <5 miles  1.08 (1.02-1.14)  1.08 (1.03-1.14)  1.09 (1.03-1.15)    
5 to <10 miles  1.01 (0.95-1.08)  1.04 (0.98-1.11)  1.04 (0.96-1.12)    
≥10 miles  0.93 (0.85-1.01)  0.99 (0.90-1.08)  0.99 (0.90-1.10)    
Neighborhood-level variables5          
Percent of population below federal poverty 
threshold in past 12 months 
         
Low (<10%)  1.00  1.00    1.00 





High (20 to <30%)  1.00 (0.94-1.07)  1.03 (0.95-1.11)    1.03 (0.95-1.11) 
Very high (≥30%)  0.95 (0.89-1.01)  1.01 (0.94-1.09)    1.01 (0.93-1.10) 
Unemployment rate among population 16 
years and over 
 0.95 (0.92-0.99)  1.00 (0.96-1.05)    1.00 (0.95-1.05) 
Percent of population that is black or African 
American only (non-Hispanic) 
  0.99 (0.98-0.99)   1.00 (0.99-1.01)       1.00 (0.99-1.01) 
1 Hazard ratios and confidence intervals for facility-level variables account for clustering by facility of diagnosis, and those for neighborhood-level variables 
account for clustering by Census tract.  Hazard ratios (HR) are unadjusted unless indicated as “AHR.” 
2 Adjusted hazard ratio 1: For each facility- or neighborhood-level variable, adjusting for all individual-level variables 
3 Adjusted hazard ratio 2: For all facility-level variables, adjusting for all individual-level variables 
4 Adjusted hazard ratio 3: For all neighborhood-level variables, adjusting for all individual-level variables 
5 Hazard ratios presented for continuous variables (percent unemployed and percent black) represent the risk per 10-percentage-point increase in the 
variable. 
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Figure 2.1. Kaplan-Meier survival curves of time from HIV diagnosis to viral suppression 
among persons newly diagnosed with HIV in New York City in 2006-2010 and followed 
through 2012 
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Figure 2.1b. By patient volume (the number of HIV diagnoses made annually by the health care 
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Figure 2.1c. By type of facility that diagnosed the patient (p<0.01) 
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Chapter 3. Multilevel analysis of individual, health care facility, and neighborhood 
characteristics associated with HIV virologic failure after suppression among 
persons newly diagnosed with HIV in New York City 
Introduction 
New York City (NYC) is home to more than 7% of all persons newly diagnosed with HIV in the 
United States (US) each year.[1, 2]  Reduction of each person’s HIV viral load (VL) to low or undetectable 
levels (e.g., ≤400 copies/mL) is called viral suppression and is typically achieved by antiretroviral therapy 
(ART) treatment.[4]  Viral suppression slows progression of HIV disease [7] and reduces the likelihood of 
onward sexual transmission.[8]  As few as 20% of PLWHA were thought to be suppressed in the US in 
the early 2000s, while today most estimates exceed 50%;[10-14] in NYC, it was 59% in 2010.[14]  The 
US National HIV/AIDS Strategy’s 2015 goal is a 20% increase in the proportion of persons virally 
suppressed, within several populations most affected by HIV (blacks, Hispanics, and gay and bisexual 
men).[9] 
Epidemiologic studies have rarely examined VL over time or in terms of factors other than 
individual demographics and clinical characteristics.  Most published population-level viral suppression 
estimates, including those in the HIV care continuum literature, refer only to the most recent VL 
measure.[10, 13]  A single VL measure may not indicate maintenance of suppression (also referred to as 
sustained suppression).[16]  The few population-based studies following individuals’ viral loads over time 
have found that a substantial proportion do not maintain suppression long; for example, 18% of New 
Yorkers newly diagnosed in 2006-2009 experienced virologic failure (loss after achievement of 
suppression) within 12 months of suppression.[15, 17-19]  While the main driver of virologic failure is poor 
adherence to ART, a study using NYC data found that more rapid failure after suppression was also 
associated with individual-level demographic characteristics, e.g., black race, younger age, female sex at 
birth, baseline clinical status indicators such as CD4 count and VL, and earlier calendar year of diagnosis 
(i.e., failure rates have declined over time).[15]  Further, some of these characteristics are known 
mediators of adherence. Studies of virologic failure may benefit from the addition of variables describing 
more macro-level or structural factors, such as the characteristics of the health care facilities where 
people receive care and the neighborhoods where they live.  For example, facility characteristics, such as 
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type of clinical setting, accessibility (including travel distance for patients), the support offered to patients, 
and physician experience have been shown to influence intermediary outcomes such as receipt of and 
adherence to ART, both necessary steps for achievement and maintenance of suppression.[31-34]  
Moreover, neighborhood factors such as lower area-level socioeconomic status have been associated 
with delayed initiation of treatment and excess mortality.[31, 33, 39, 43, 93] However, few studies on 
virologic failure have included facility or neighborhood characteristics. 
Information about the characteristics associated with virologic failure is now included in many HIV 
surveillance registries [15, 25, 52], and these characteristics will become increasingly important to identify 
as more persons with HIV receive ART and achieve suppression.  Thus, to examine these factors, we 
investigated the effect of individual, health care facility, and neighborhood characteristics on HIV virologic 
failure among New York City residents aged 13 years and older who were diagnosed with HIV between 
2006 and 2010 and had achieved viral suppression. The results of this analysis may be used to improve 
public health by identifying groups of persons who, because of individual or structural factors, are 
vulnerable to virologic failure and who might benefit from interventions accounting for these factors to 
improve ART adherence. 
Methods 
Data sources 
This retrospective analysis used data from the NYC HIV surveillance registry reported by 
September 30, 2013, the 2010 US Census,[54] and the 2011 American Community Survey.[55]  The 
surveillance registry includes all persons diagnosed and reported with AIDS in NYC since 1981 and HIV 
since 2000.  It gathers information by medical record review, provider report at diagnosis, personal 
interviews with patients, and HIV-related laboratory tests, which are electronically reported to surveillance 
for all cases diagnosed and/or receiving care in NYC. 
The surveillance registry includes individual-level demographic and clinical information collected 
at the time of first report of HIV diagnosis or first VL test indicating suppression, address of residence at 
diagnosis, and HIV-related laboratory test results from 2006-2012 for all New Yorkers newly diagnosed 
with HIV and achieving viral suppression.  Laboratory reports contain the test type, specimen collection 
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date, result, and submitting provider or facility.  Health care facility data from 2006-2012 were obtained 
from the registry and linked to cases according to the facility that conducted the first VL test indicating 
suppression for each case.  Finally, neighborhood data were acquired from the 2010 US Census and the 
2011 American Community Survey 5-year estimates.  Patient address of residence at diagnosis, obtained 
from the registry, was geocoded to the Census tract to link tract-level neighborhood data from the US 
Census and American Community Survey to individuals. Although the baseline time point for this analysis 
was first viral suppression, residence at diagnosis rather than at first suppression was used because 
Census tract-level residence data at first suppression were not available. 
Population 
Our analysis population was drawn from NYC residents who were newly diagnosed with HIV 
between 2006 and 2010, were at least 13 years of age at diagnosis, and achieved viral suppression 
(≤400 copies/mL) ≥31 days following diagnosis and by 12/31/2012 (N=10,232 persons).  The cut-off for 
suppression was 400 copies/mL because this was the highest lower detectable limit of all VL assays 
being used during the study period.[59]  Persons were then excluded from the analysis population if their 
death date appeared to precede their first suppression date (n=6), they had an HIV diagnosis date that 
was potentially misclassified (n=653; e.g., they had neither a Western blot confirmatory test within 31 
days of diagnosis nor a diagnosis of acute HIV infection), the name of the facility of diagnosis or 
suppression was missing (n=15), their address of residence and of facility of diagnosis or suppression 
were equivalent, possibly indicating a homeless or institutionalized person, for whom characteristics of 
the neighborhood of residence might influence health outcomes differently (n=415), they were diagnosed 
or suppressed at a correctional facility or suppressed at a screening/diagnostic facility, possibly indicating 
an institutionalized person or a misclassified care facility type (n=205), or their neighborhood-level 
characteristics were unknown (n=11).  These exclusions yielded an analytical sample of 8,927 persons 
(see Appendix 1). 
Outcome 
The outcome of interest was virologic failure, defined as having a VL ≥1,000 copies/mL or not 
having any VL test for 12 consecutive months.  The 1,000-copy cutoff permitted a modest increase in VL 
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above 400 that would not necessarily signal virologic failure but rather perhaps just a “blip.”[60]  
Additionally, risk of HIV transmission from a person with VL up to 1000 is low.[8, 61]  Requiring VL tests 
every 12 months in order to be classified as maintaining suppression ensured at least minimal 
engagement in care, as quarterly testing is recommended for most persons with HIV.[70]  The 12-month 
requirement also provided an endpoint for persons who dropped out of care, since care is required to 
detect any VL, and it was not reasonable to assume that persons who dropped out of care in NYC would 
remain suppressed.  Censoring occurred at whichever came earlier: death or the end of the follow-up 
period.  Follow-up time was calculated as the number of days from the date of first viral suppression after 
HIV diagnosis to the earliest of these dates: virologic failure, death, or 12/31/2012. 
Covariates 
Individual-level variables  
Most of the demographic characteristics in our analyses were shown in previous analyses to be 
associated with virologic failure among newly diagnosed New Yorkers who had achieved viral 
suppression.[15]  Demographic characteristics (age, sex at birth, race/ethnicity, area of birth), HIV 
transmission risk (also referred to as transmission categories), viral suppression date, viral loads, CD4 
counts, and address of residence at diagnosis were acquired from the NYC HIV surveillance registry.  
Age at viral suppression was calculated from birth date to date of first suppression and 
categorized as 13-19, 20-29, 30-39, 40-49, 50-59, and 60+.[2]  Sex at birth was specified as collected, 
male or female.  Race was collected as white or Caucasian, black or African American, Asian or Pacific 
Islander, and Native American.  Ethnicity was collected as Hispanic, non-Hispanic, or unknown.  Race 
and ethnicity were combined into a single variable in which all persons of Hispanic ethnicity were 
classified as Hispanic, and non-Hispanics were classified as black, white, or other non-Hispanic race 
(which included Asians and Pacific Islanders, Native Americans, and multiracial persons).[15]  Area of 
birth was collected as country of birth when available or region of birth and categorized as born in the US, 
US dependency (e.g., Puerto Rico), foreign country, or unknown place of birth.[68] 
HIV transmission risk category was based on pre-diagnosis risk behaviors documented in the 
medical record and/or self-reported at the time of diagnosis (e.g., injection drug use, male-male sex) and 
the sex, HIV status (e.g., HIV-positive), and risk (e.g., injection drug use) of the pre-diagnosis 
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heterosexual-sex partners reported by the case.[69]  This information was combined into hierarchical 
categories: injection drug use, men who have sex with men, heterosexual sex, and other or unknown 
(which included perinatal transmission).[15]  To be classified as most likely having acquired HIV through 
heterosexual sex, persons must have reported pre-diagnosis sex with a partner of the other sex who was 
HIV-infected, had injected drugs, or had received blood products.  In addition, females could be classified 
as heterosexual if they had probable heterosexual transmission noted in their medical record, reported 
sex with a male and no history of drug injection, or had any one of several behaviors associated with 
heterosexual transmission (history of prostitution, multiple sex partners, sexually transmitted disease, 
crack/cocaine use, or sex with a bisexual male).[2] 
CD4 count (if any) at suppression was based on the first CD4 count within 31 days before or after 
suppression and categorized as 0-199, 200-349, 350-499, and ≥500 cells/mL. 
Health care facility-level variables 
Characteristics of the facility of first suppression include annual HIV patient volume, type, and 
patient-to-provider distance, all of which could be ascertained or calculated based on information in the 
NYC HIV surveillance registry. HIV patient volume was collected as number of HIV-positive patients cared 
for annually, based on persons receiving a VL or CD4 test (as reported to surveillance) at that facility in 
the year of the patient’s viral suppression, and categorized as <250, 250-999, 1,000-1,999, and ≥2,000 
patients per year.[33, 73]  Facility type was categorized as hospital, private physician (also referred to as 
private practice), other outpatient facility, and other or unknown (<10 persons had a known facility but 
unknown type), as potential indicators of the availability of ancillary services (at the first and third types) 
[32].  These two variables of HIV patient volume and facility type were further combined (see Appendix 7), 
with patient volume dichotomized as <1,000 (small) and ≥1,000 (large), to better capture underlying 
concepts.  Patient-provider distance was calculated as the distance in miles using the most direct street 
route from patient residence to the facility where suppression was first detected (based on the XY 
coordinates of each) using Network Analyst in ArcMap 10.0 (ESRI, Redmonds, CA) and a network 
dataset of NYC streets that is used within the NYC Department of Health and Mental Hygiene (see 
Appendix 4).  This distance was categorized as <1 mile, 1-<5 miles, 5-<10 miles, and ≥10 miles. 




Analyses included two Census tract-level SES measures from 2011 American Community Survey 
(ACS) 5-year estimates; this is the recommended source for such statistics because the 2010 decennial 
census did not collect them.[74]  These measures have previously been associated with HIV or sexually 
transmitted infections or HIV outcomes and include percent of residents with incomes under the federal 
poverty threshold[31, 33, 39, 40, 47, 75] and percent unemployed among residents aged 16 years and 
older.[31, 39, 41, 75]  Census 2010 provided data on percent of non-Hispanic black residents.[74]  The 
values for percent unemployed and percent black were divided by 10 and entered into a proportional 
hazards regression as continuous variables with every unit representing a 10-percentage-point difference.  
Poverty was categorized as 0 to <10% (low-poverty), 10 to <20% (medium-poverty), 20 to <30% (high-
poverty), and 30 to 100% (very-high-poverty), based on recommendations of the NYC health 
department.[76]  These particular neighborhood-level variables (poverty, unemployment, and black race) 
have been used together previously.[43]  
Statistical analysis 
Descriptive statistics were calculated for selected characteristics at the individual, facility, and 
neighborhood levels and presented for the overall population and according to virologic failure status 
within 12 months (365 days) of suppression.  Association between each variable and virologic failure 
within 12 months was measured using Chi-squared tests.  Differences in median days to failure by the 
end of the follow-up period were determined using Mann-Whitney U test.  
Kaplan-Meier curves showing the number of days from suppression to failure were generated by 
key individual, health care facility, and neighborhood characteristics.  Log-rank tests were used to indicate 
differences between groups. 
Cox proportional hazards regressions estimated the association of individual, facility, and 
neighborhood-level factors with failure in crude and adjusted models.  Robust sandwich estimation of the 
standard errors was used to account for correlations of individual outcomes within either facility of 
suppression or neighborhood (Census tract).[62, 63]  We fit several models after estimating unadjusted 
rates for virologic failure for each individual, facility, and neighborhood characteristic.  We began by 
estimated hazards of virologic failure for each individual characteristic after adjustment for all other 
        
40 
 
individual characteristics (i.e., without any facility or neighborhood characteristics).  Next, we fit models to 
estimate the hazards for each facility and each neighborhood characteristic, after controlling for individual 
characteristics.  Specifically, because we were exploring the role of structural or macro-level variables in 
virologic failure, each variable at the facility or neighborhood level was entered, one at a time, into a 
model with all individual characteristics.  Finally, two models were fitted to estimate the adjusted hazards 
for 1) all individual and facility characteristics and 2) all individual and neighborhood characteristics.  
Model fit was compared with a Χ2 test according to difference in -2LL and degrees of freedom (see 
Appendix 7). 
All analyses were conducted using SAS 9.2 (SAS Institute, Cary, NC).  Ethical approval for the 
analysis was granted by the Institutional Review Boards of Lehman College of the City University of New 
York and of the New York City Department of Health and Mental Hygiene. 
Results 
Descriptive statistics 
Of 8,927 New Yorkers newly diagnosed with HIV in 2006–2010 and achieving viral suppression, 
approximately three-quarters were 20-49 years old (78.9%), male (74.2%), and black or Hispanic (79.9%; 
Table 3.1).  Approximately half were US-born (52.7%), were men who have sex with men (46.8%), and 
had CD4 counts ≥350 at suppression (49.6%).  Almost one-fifth (18.2%) of the population experienced 
failure within 12 months of suppression (Table 3.1).  Compared to persons who did not experience failure 
within 12 months of suppression, those who did were more likely to be younger, female, black or 
Hispanic, born in a US dependency, and injection drug user or heterosexual (all p-values <0.001). 
Virologic failure occurred at a median of 728 days, i.e., approximately 2 years after achievement 
of suppression (Table 3.1).  Failure happened most quickly among persons who were younger vs. older, 
black or Hispanic vs. white, born in the US or a US dependency vs. foreign-born, or injection drug user 
vs. other risk categories.  Failure was also quicker among persons who had suppressed in later vs. earlier 
calendar years (but likely, in part, as an artifact of the shorter follow-up time for those suppressing in later 
years), had higher vs. lower CD4 counts at suppression, or first achieved suppression in large outpatient 
facilities or large private practices vs. smaller or other facility types.  Differences in time to failure were 
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most prominent by CD4 count (827 days among persons with CD4 0-199 vs. 599 among 500+). These 
differences were confirmed by the Kaplan-Meier survival curves (by CD4 count, p=0.0074; Figure 3.1a). 
Approximately half of the population first achieved suppression in facilities that cared for ≥1,000 
HIV-positive persons (52.7%), were hospitals (54.7%), and were 1 to <5 miles from their home (52.5%; 
Table 3.2); and lived in neighborhoods where ≥20% of the population was below the poverty threshold 
(i.e., high or very high poverty; 58.0%).  Among persons in the analysis population, the mean 
neighborhood-level unemployment rate was 10.7% (for reference, in comparison, the citywide rate was 
9.5%[55]), and the mean neighborhood-level percent black was 33.3% (the citywide rate was 22.8%[94]). 
When compared to persons who maintained suppression, those who experienced failure within 
12 months of first suppression were most likely to have been first suppressed at large hospitals or small 
outpatient facilities and to be residents of higher-poverty neighborhoods (Table 3.2). Differences in failure 
by facility type and patient volume as well as by neighborhood poverty level were clearly apparent in 
Kaplan-Meier survival curves (all p<0.0001; facility type and patient volume and neighborhood poverty 
shown in Figures 3.1b-3.1c). 
Modelling individual characteristics 
Table 3.3 presents the unadjusted and adjusted HRs for individual characteristics on HIV virologic 
failure among persons newly diagnosed with HIV and achieving viral suppression in NYC.  The 
unadjusted HRs show that persons who were younger, female, black or Hispanic, born in the US or a US 
dependency, not men who have sex with men, and who had a CD4 count ≥500 cells/mL experienced 
rates of failure that were elevated at least 10% (range 11% to 95%). 
After adjustment for individual characteristics only, the rate of virologic failure remained higher 
among younger persons, blacks and Hispanics, US- and US-dependency born persons, heterosexuals 
and injection drug users, and persons with CD4 counts ≥500 cells/mL at suppression, compared with 
others.  For example, rates were between 21 and 101% higher for persons 13-49 years old relative to 
those 60 and older (e.g., 20-29 years old, 56%[95%CI=1.32-1.85]).  These findings remained nearly 
identical when adjusting for either facility or neighborhood characteristics (adjusted hazard ratios [AHRs] 
2 and 3 in Table 3.3). 
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Modelling facility and neighborhood characteristics 
Table 3.4 presents the unadjusted and adjusted HRs for facility and neighborhood characteristics 
on HIV virologic failure among persons newly diagnosed and achieving suppression with HIV in NYC.  
The unadjusted HRs show higher failure rates among persons suppressed at hospitals and small 
outpatient facilities, and among residents of neighborhoods with higher proportions of residents who were 
poor, unemployed, or black, compared with others. 
Most facility-related findings remained the same after adjustment for individual characteristics 
alone, and then individual characteristics as well as either all facility or all neighborhood characteristics.  
However, persons suppressed at small private practices or at small facilities other than hospitals, 
outpatient facilities, or private practices, became as likely as persons in large hospitals to experience 
failure (when controlling for all individual and facility characteristics, AHR[95%CI]=0.94[0.81-1.08]).  The 
model with all individual- and facility-level variables had the best fit (-2LL: 64,069; p<0.0001 vs. the model 
with all individual-level variables only; see Appendix 7).  Among neighborhood characteristics, only high 
or very high poverty remained associated with failure in models adjusted for individual characteristics 
(e.g., AHR=1.19[95% CI=1.06-1.34] for very-high vs. low poverty). 
Discussion 
Virologic failure after suppression was experienced more quickly among persons who were 
younger, black or Hispanic, US- or US-dependency-born, non-MSM, and diagnosed in earlier years, and 
among persons with higher CD4 counts at suppression, after controlling for facility or neighborhood 
characteristics. Similarly, persons receiving care at facilities that were not large outpatient facilities or 
large private practices, and residents of higher-poverty neighborhoods, had higher failure rates than 
others, after controlling for individual and other facility or neighborhood characteristics. 
Our findings about individual, facility, and neighborhood characteristics associated with failure 
were largely consistent with the literature [15, 31-34, 39] and also provided unique information about 
teenagers.  Several studies have examined the influence of age on suppression and failure among 
persons 18 or 21 years of age and older.[15, 95, 96]  However, few studies of virologic failure have 
included younger teens.  In our analysis, persons in the 13-19-year age group (28% of whom were under 
18; see Appendix 7) had the highest rate of failure.  Teenagers have been found to have lower rates of 
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retention in care and ART adherence.[77, 78]  Higher failure rates among persons in care at facilities 
other than large outpatient facilities or large private practices possibly may be because those facilities 
were less likely to provide services supporting retention, adherence, and case management (in some 
cases, due to their smaller size), which have been shown to facilitate retention in care;[79, 80] their 
providers were less likely to adhere to HIV-related care recommendations;[81] or the patients had clinical, 
behavioral, or socioeconomic characteristics not captured in our models, such as addiction, other mental 
illness, or individual poverty, that left them less able to maintain high adherence even if they were able to 
see a physician, obtain ART, and achieve suppression.  The potential explanations of individual poverty 
or of mental illness (if so disabling as to qualify someone for public health insurance) would be consistent 
with previous findings that persons with private insurance were more likely to sustain viral suppression 
than persons insured by Medicaid or Medicare, or who were uninsured.[20]  Our analysis was unable to 
identify which of these factors might account for the higher failure rates among persons achieving 
suppression even at large hospitals, many of which are Designated AIDS Centers.  Our findings about 
neighborhood-level poverty being associated with failure were consistent with previous studies on 
neighborhood-level socioeconomic factors and care-related outcomes[31, 33, 38-42].  However, 
percentages of neighborhood residents who were black or unemployed were not associated with failure 
after controlling for neighborhood-level poverty.  This is consistent with previous findings that 
neighborhood-level poverty, rather than other factors such as neighborhood-level racial/ethnic makeup or 
unemployment rates, was the socioeconomic indicator most predictive of health disparities.[47]  This also 
suggests that the many resources available for low-income PLWHA in NYC to receive care, medication, 
and other forms of support, may not entirely eliminate the effects of poverty on HIV-related health 
outcomes. 
Prior literature found that shorter distance to the nearest HIV care site was associated with 
achievement of viral suppression among persons retained in care.[84]  However, we found no association 
between distance from a person’s residence to the facility at which s/he was first suppressed (i.e., where 
s/he was receiving care) and time from first viral suppression to failure. The extensiveness of NYC’s 
systems of HIV care and public transit,[97] coupled with New York State’s generous benefits and services 
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for persons with HIV,[98] may have helped render patient-provider distance irrelevant to virologic failure – 
even as a relationship between neighborhood-level poverty and failure persisted. 
In summary, adding facility and neighborhood variables to population-level models of virologic 
failure after suppression did not change the individual characteristics associated with failure but did permit 
the identification of several structural (i.e., facility and neighborhood) factors also associated with failure.  
These structural factors may be useful targets for interventions aiming to increase maintenance of 
suppression among persons with HIV, or may be used to indicate persons who would benefit from 
additional support to maintain suppression, thereby improving their health and reducing transmissibility. 
Limitations 
Our analysis was subject to limitations typical of population-based, multilevel, geographic, or 
surveillance-based analyses.  Namely, some people’s VL was measured only at irregular intervals, and 
outmigration could not be directly ascertained.  Data on several factors that may influence maintenance of 
suppression were not available in the HIV surveillance registry.  Additionally, it was difficult to identify the 
level at which certain characteristics influenced the outcome.  Finally, findings may have been sensitive to 
the geographic level of aggregation, i.e., Census tract, or to residential moves between diagnosis and 
suppression.  These factors may have caused over- or underestimation of hazard ratios. 
Our analysis had VL data only when persons sought care, which was at their discretion and not 
necessarily at regular intervals.  Persons may have experienced virologic failure sometime before it was 
measured in a VL test or after dropping out of care.  Persons not in care in NYC for up to 12 months after 
a suppressed VL were presumed to be present and suppressed, although prior to the 12-month mark 
they may have experienced failure or moved out of NYC and maintained suppression elsewhere.  It is not 
clear whether irregular testing and unascertained outmigration would have increased or decreased our 
hazard ratios.  However, the majority of New Yorkers newly diagnosed with HIV between 2006 and 2010 
were engaged in care at intervals that were both consistent with federal guidelines and sufficiently 
frequent to produce population-level estimates of suppression.  Specifically, among newly diagnosed 
persons with at least one VL test between diagnosis and death, persons diagnosed in 2006, with the most 
follow-up, had a median of 17 VL tests (IQR: 10-23) and the median interval between tests was 120 days 
(4 months; IQR: 95-182 days), while persons diagnosed in 2010 had a median of 8 tests (IQR: 5-10) and 
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the median interval between tests was 101 days (3 months; IQR: 85-139 days).  Additionally, there is 
likely to be little under-ascertainment of failure among persons in NYC, for several reasons.  First, a 
recently diagnosed and virally suppressed person with no subsequent blood draw for VL tests cannot 
receive ART by prescription and therefore is unlikely to maintain suppression.[72]  Second, a newly 
suppressed person was in NYC as recently as his/her suppression date, and thus, had relatively little time 
to leave NYC.  Third, the system of care and services, generous benefits, and large HIV-positive 
population in NYC have long made it a relatively attractive place for HIV-positive persons to live and 
receive care; this likely promotes retention and suppression. 
Because the HIV surveillance system provided the individual-level data in our analysis, 
information about several individual factors that may influence the maintenance of suppression were not 
available.  Specifically, mental illness and addiction that are not well-controlled may affect a person’s 
ability to adhere to ART, potentially triggering failure after suppression, but mental health and substance 
use (other than injection drug use) are not necessarily well-documented in the medical record at the 
facility diagnosing HIV nor well-ascertained by surveillance.  Further, information about ART adherence, 
the primary driver of maintenance of suppression, was not available. 
Characteristics measured at one level in our models may have acted at another level.  For 
example, poverty was measured at the neighborhood level only and was found to be significantly 
associated with virologic failure.  It is possible that this association was present only because there is an 
association between neighborhood- and individual-level poverty, which was not measured, and failure 
(and individual- and neighborhood-level poverty are correlated), or alternatively, that individual-level 
poverty would not in fact have been associated with failure.  This limitation is not unique to our analysis 
but rather is characteristic of multilevel analyses.[89, 90] 
As in any geographic analysis, our findings may have been subject to the modifiable areal unit 
problem, meaning they were sensitive to the geographic level (Census tract) at which patient residence 
and facility location were measured.[99-101]  Analyses at other levels would have grouped people 
differently, e.g., in smaller or larger areas, or with different geographic boundaries that would have 
resulted in different aggregations of people, and may have produced different findings.  Further, because 
of the edge effect, adjacent or nearby Census tracts may have had cross-boundary similarities and 
        
46 
 
influences, largely due to the movement of people across multiple Census tracts.[102, 103]  This could 
dilute the effect of differences across neighborhoods. 
Because Census tract-level residence information at first viral suppression was not available, we 
assumed that the neighborhood characteristics of a person’s residence at diagnosis were comparable to 
those at first suppression.  However, more than 21% of persons in our analysis may have changed 
Census tract of residence between diagnosis and suppression.  Studies have shown that persons who 
move typically go to similar neighborhoods.[104]  However, in the population in our analyses, many of the 
21% who moved went to Census tracts with different characteristics, e.g., poverty level, than the Census 
tracts they were living in at diagnosis.  It is not possible to determine whether this misclassification of 
persons’ neighborhood-level variables was differential or non-differential (see Appendix 7). 
Strengths 
This is among the first analyses in the US to investigate the influence of facility and neighborhood 
on HIV outcomes using surveillance data. [31, 33, 35, 87]  The data were drawn from population 
surveillance in the largest HIV epidemic in the US, in a diverse US city.  The analysis combined data from 
multiple sources to assess the potential influence on virologic failure of factors beyond the individual.  
Mandatory electronic reporting of laboratory tests in NYC provided information about all measured VLs for 
all HIV-positive persons receiving care in NYC, as opposed to in a clinical trials environment, where 
findings can differ from those in a population setting.  To assign area-based characteristics to individuals, 
we used patient address geocoded to the Census tract, which is the gold standard for detection of public 
health disparities;[47] other geographic analyses of HIV care outcomes have used only counties and ZIP 
codes, which are much larger than Census tracts.  Due to NYC’s heterogeneity, the smaller geographic 
unit (tract) was preferable.  We filled a gap in the literature by including teenagers, who are subject to the 
same treatment guidelines as adults but whose age may have contributed to quicker virologic failure than 
among older persons.[78]  The survival analysis method permitted the analysis of VL data over a long 
period of time and did not require multiple VL tests as an inclusion criterion. 




Our findings suggest that persons with HIV who are younger, black or Hispanic, US- or US-
dependency-born, non-MSM, or have higher CD4 counts at suppression; who seek care at facilities other 
than large outpatient facilities or large private practices; or who live in high- or very-high-poverty 
neighborhoods; were more likely to experience virologic failure.  These populations may need more 
assistance after viral suppression in the areas of retention in care or ART adherence.  These facility- and 
neighborhood-level effects were found even in NYC, the setting for this analysis, i.e., a large, densely 
populated city with extensive systems of high-quality HIV care, social services, and public transportation.  
It is possible that the effects would have been even larger in a setting other than NYC that may not have 
been as well-resourced vis-à-vis medical facilities and transportation systems.  It is possible that residents 
of poorer neighborhoods in NYC might benefit from even better care that permitted them to maintain 
suppression at comparable rates as residents of wealthier neighborhoods; rectifying this disparity may 
require targeted adherence support services or additional general poverty alleviation.  Further 
investigation is needed to understand why lower rates of failure were seen among patients at large 
outpatient facilities and large private providers, which serve a minority of New Yorkers with HIV.  
Additional investigation would also be valuable to suggest how large hospitals – many of which are 
Designated AIDS Centers, and which detected the first viral suppression for 43% of newly diagnosed 
New Yorkers – can better support their patients in maintaining suppression. 
 




Table 3.1. HIV virologic failure1 within 12 months after first viral suppression among persons newly diagnosed with HIV in 
New York City in 2006-2010 and followed through 2012, by individual-level characteristics 
  Total   
No virologic 
failure* within 
12 months of 
suppression   
Virologic failure1 within 12 months of 
suppression   
Median time from 
suppression to failure 
  Distribution (n)  Distribution (n)  Distribution (n) Prevalence p-value2  
Median 
(IQR3) days p-value4 
Total 100.0 (8,927)   100.0 (7,300)   100.0 (1,627) 18.2     728 (864)   
Age group (years)       <0.0001   <0.0001 
13 - 19 2.2 (196)  1.8 (134)  3.8 (62) 31.6   571 (746)   
20 - 29 26.4 (2,360)  25.8 (1,887)  29.1 (473) 20.0   653 (748)   
30 - 39 27.0 (2,409)  27.5 (2,009)  24.6 (400) 16.6   770 (887)   
40 - 49 25.5 (2,274)  25.6 (1,866)  25.1 (408) 17.9   741 (904)   
50 - 59 13.8 (1,235)  14.2 (1,036)  12.2 (199) 16.1   801 (940)   
≥60 5.1 (453)  5.0 (368)  5.2 (85) 18.8   796 (989)   
Sex at birth       <0.0001   0.0564 
Male 74.2 (6,623)  75.6 (5,518)  67.9 (1,105) 16.7   742 (841)   
Female 25.8 (2,304)  24.4 (1,782)  32.1 (522) 22.7   708 (930)   
Race/Ethnicity       <0.0001   <0.0001 
Black 46.7 (4,167)  45.6 (3,330)  51.4 (837) 20.1   685 (865)   
Hispanic 33.2 (2,964)  32.4 (2,362)  37.0 (602) 20.3   732 (918)   
White 16.7 (1,489)  18.4 (1,341)  9.1 (148) 9.9   807 (749)   
Other 3.4 (307)  3.7 (267)  2.5 (40) 13.0   908 (870)   
Country of birth       0.0004   <0.0001 
US 52.7 (4,703)  52.5 (3,829)  53.7 (874) 18.6   689 (823)   
US Dependency 4.5 (404)  4.1 (302)  6.3 (102) 25.2   685 (959)   
Foreign 32.6 (2,906)  32.9 (2,402)  31.0 (504) 17.3   791 (913)   
Unknown 10.2 (914)  10.5 (767)  9.0 (147) 16.1   818 (981)   




HIV transmission risk       <0.0001   <0.0001 
Men who have sex 
with men 
46.8 (4,181)  48.8 (3,561)  38.1 (620) 14.8   753 (808)   
Injection drug use 
history 
4.7 (423)  4.2 (307)  7.1 (116) 27.4   550 (975)   
Heterosexual 26.1 (2,328)  24.9 (1,815)  31.5 (513) 22.0   711 (900)   
Other or unknown 22.3 (1,995)  22.2 (1,617)  23.2 (378) 18.9   748 (946)   
Year of suppression       <0.0001   <0.0001 
2006 6.1 (549)  6.0 (441)  6.6 (108) 19.7   1,077 (1,869)   
2007 12.7 (1,131)  12.2 (894)  14.6 (237) 21.0   1,255 (1,577)   
2008 16.6 (1,478)  16.4 (1,195)  17.4 (283) 19.1   1,241 (1,225)   
2009 20.2 (1,803)  20.1 (1,468)  20.6 (335) 18.6   1,138 (836)   
2010 22.7 (2,030)  23.3 (1,699)  20.3 (331) 16.3   809 (451)   
2011 14.5 (1,291)  14.1 (1,029)  16.1 (262) 20.3   516 (264)   
2012 7.2 (645)  7.9 (574)  4.4 (71) 11.0   194 (188)   
CD4 count at 
suppression 
      0.4633   <0.0001 
0-199 19.3 (1,722)  19.0 (1,390)  20.4 (332) 19.3   827 (1,089)   
200-349 22.5 (2,006)  22.5 (1,641)  22.4 (365) 18.2   816 (941)   
350-499 22.5 (2,012)  22.8 (1,664)  21.4 (348) 17.3   768 (836)   
500+ 27.1 (2,415)  26.9 (1,964)  27.7 (451) 18.7   599 (674)   
No CD4 count 8.6 (772)   8.8 (641)   8.1 (131) 17.0     718 (922)   
1 Virologic failure was defined as first viral load of ≥1,000/mL or 12 months without a viral load test. 
2 p-value: Chi-square test of association between each variable and virologic failure 
3 IQR: Interquartile range, i.e., 3rd quartile minus 1st quartile 
4 p-value: Mann-Whitney U test of differences by each variable in median days to failure 





Table 3.2. HIV virologic failure1 after suppression among persons newly diagnosed with HIV in New York City in 2006-
2010 and followed through 2012, by characteristics of the health care facility at which persons were diagnosed and the 
neighborhood (Census tract) persons were living in at diagnosis 
  Total  
No virologic 
failure* within 12 
months of 
suppression   
Virologic failure1 within 12 months of 
suppression   





(n) or Mean 




Total 100.0 (8,927)   100.0 (7,300)   100.0 (1,627) 18.2     
728 (864) 
  
Facility-level variables            
Number of HIV-positive 
patients cared for 
annually by health care 
facility where patient 
suppressed (patient 
volume) 
      0.1007   0.2227 
<250 21.9 (1,951)  21.9 (1,596)  21.8 (355) 18.2   711 (831)   
250 to 999 25.4 (2,267)  25.7 (1,874)  24.2 (393) 17.3   731 (833)   
1,000 to 1,999 26.2 (2,342)  25.7 (1,877)  28.6 (465) 19.9   742 (931)   
≥2,000 26.5 (2,367)  26.8 (1,953)  25.4 (414) 17.5   748 (857)   
Type of facility where 
patient suppressed 
       <0.0001   <0.0001 
Hospital 54.7 (4,879)  53.5 (3,904)  59.9 (975) 20.0   741 (925)   
Outpatient 25.7 (2,298)  25.5 (1,864)  26.7 (434) 18.9   678 (789)   
Private physician 17.5 (1,564)  19.0 (1,386)  10.9 (178) 11.4   815 (817)   




Other or unknown 2.1 (186)  2.0 (146)  2.5 (40) 21.5   578 (746)   
Facility type by patient 
volume 
      <0.0001   <0.0001 
Hospital, ≥1,000 43.3 (3,865)  42.1 (3,074)  48.6 (791) 20.5   732 (936)   
Hospital, <1,000 11.4 (1,014)  11.4 (830)  11.3 (184) 18.1   761 (887)   
Outpatient, ≥1,000 8.3 (738)  9.0 (655)  5.1 (83) 11.2   739 (691)   
Outpatient, <1,000 17.5 (1,560)  16.6 (1,209)  21.6 (351) 22.5   645 (824)   
Private physician, 
≥1,000 
1.2 (106)  1.4 (101)  0.3 (5) 4.7   977 (714)   
Private physician, 
<1,000 
16.3 (1,458)  17.6 (1,285)  10.6 (173) 11.9   794 (814)   
Other or unknown, 
<1,000 
2.1 (186)  2.0 (146)  2.5 (40) 21.5   578 (746)   
Distance between 
patient and facility 
      0.0925   0.1522 
<1 mile 15.8 (1,409)  15.5 (1,134)  16.9 (275) 19.5   724 (881)   
1 to <5 miles 52.5 (4,684)  52.5 (3,830)  52.5 (854) 18.2   740 (869)   
5 to <10 miles 22.7 (2,024)  23.1 (1,687)  20.7 (337) 16.7   741 (839)   
≥10 miles 9.1 (810)  8.9 (649)  9.9 (161) 19.9   684 (857)   
Neighborhood-level 
variables 
           
Percent of population 
below federal poverty 
threshold in past 12 
months 
       <0.0001   <0.0001 
Low (<10%) 15.9 (1,420)  17.0 (1,238)  11.2 (182) 12.8   832 (850)   
Medium (10 to <20%) 26.1 (2,328)  26.8 (1,956)  22.9 (372) 16.0   750 (827)   
High (20 to <30%) 25.5 (2,278)  25.4 (1,854)  26.1 (424) 18.6   726 (850)   
Very high (≥30%) 32.5 (2,901)  30.8 (2,252)  39.9 (649) 22.4   658 (913)   
Percent of population 16 
years and over that was 
unemployed in past week 
10.7 (5.6)  -  - - N/A  - N/A 




Percent of population 
that is black or African 
American only (non-
Hispanic) 
33.3 (29.0)   -   - - N/A   - N/A 
1 Virologic failure was defined as first viral load of ≥1,000/mL or 12 months without a viral load test. 
2 p-value: Chi-square test of association between each variable and virologic failure 
3 IQR: Interquartile range, i.e., 3rd quartile minus 1st quartile 
4 p-value: Mann-Whitney U test of differences by each variable in median days to failure 
  





Table 3.3. Proportional hazards regressions of HIV virologic failure1 after suppression among persons newly diagnosed 
with HIV in New York City in 2006-2010 and followed through 2012 (N=8,927), by individual-level characteristics 
    
HR                                 
(95% CI)1   
AHR 1                      
(95% CI)1,2   
AHR 2                         
(95% CI)1,3   
AHR 3                          
(95% CI)1,4 
Age group (years)         
13 – 19  1.95 (1.52-2.49)  2.01 (1.57-2.57)  2.00 (1.53-2.62)  1.97 (1.53-2.52) 
20 – 29  1.35 (1.14-1.59)  1.56 (1.32-1.85)  1.61 (1.33-1.93)  1.54 (1.31-1.82) 
30 – 39  1.10 (0.93-1.29)  1.27 (1.08-1.50)  1.32 (1.10-1.58)  1.26 (1.07-1.49) 
40 – 49  1.11 (0.93-1.31)  1.21 (1.02-1.43)  1.24 (1.04-1.47)  1.20 (1.02-1.42) 
50 – 59  0.97 (0.81-1.16)  0.98 (0.82-1.17)  0.99 (0.83-1.17)  0.97 (0.81-1.17) 
≥60  1.00  1.00  1.00  1.00 
Sex at birth         
Male  0.82 (0.76-0.89)  1.06 (0.95-1.19)  1.07 (0.98-1.17)  1.08 (0.96-1.20) 
Female  1.00  1.00  1.00  1.00 
Race/Ethnicity         
Black  1.54 (1.41-1.69)  1.39 (1.26-1.53)  1.31 (1.16-1.47)  1.27 (1.14-1.43) 
Hispanic  1.35 (1.22-1.49)  1.24 (1.11-1.39)  1.17 (1.02-1.35)  1.17 (1.04-1.31) 
White  1.00  1.00  1.00  1.00 
Other  0.89 (0.72-1.10)  0.92 (0.74-1.15)  0.87 (0.65-1.18)  0.90 (0.72-1.12) 
Country of birth         
US  1.19 (1.10-1.28)  1.18 (1.09-1.28)  1.19 (1.10-1.28)  1.17 (1.08-1.27) 
US Dependency  1.38 (1.19-1.60)  1.40 (1.20-1.65)  1.39 (1.19-1.64)  1.36 (1.16-1.60) 
Foreign  1.00  1.00  1.00  1.00 
Unknown  0.95 (0.84-1.06)  1.01 (0.90-1.15)  1.01 (0.88-1.16)  1.02 (0.90-1.15) 
HIV transmission risk         
Men who have sex with men  0.75 (0.69-0.81)  0.72 (0.64-0.81)  0.75 (0.67-0.84)  0.73 (0.65-0.83) 
Injection drug use history  1.22 (1.05-1.42)  1.23 (1.05-1.46)  1.23 (1.06-1.41)  1.23 (1.04-1.45) 




Heterosexual  1.00  1.00  1.00  1.00 
Other or unknown  0.87 (0.79-0.95)  0.89 (0.80-0.99)  0.90 (0.81-1.00)  0.89 (0.80-0.99) 
Year of suppression         
2006  1.17 (0.90-1.51)  1.21 (0.93-1.57)  1.21 (0.94-1.56)  1.22 (0.94-1.58) 
2007  1.16 (0.91-1.49)  1.21 (0.94-1.55)  1.20 (0.93-1.54)  1.21 (0.94-1.56) 
2008  1.10 (0.86-1.40)  1.15 (0.90-1.46)  1.14 (0.89-1.46)  1.16 (0.91-1.47) 
2009  0.98 (0.77-1.25)  1.01 (0.79-1.29)  1.00 (0.80-1.26)  1.02 (0.80-1.30) 
2010  0.94 (0.74-1.20)  0.98 (0.77-1.25)  0.98 (0.77-1.26)  0.99 (0.78-1.27) 
2011  1.00 (0.78-1.29)  1.05 (0.81-1.34)  1.05 (0.83-1.34)  1.05 (0.82-1.35) 
2012  1.00  1.00  1.00  1.00 
CD4 count at suppression         
0-199  1.00  1.00  1.00  1.00 
200-349  0.97 (0.88-1.07)  0.99 (0.89-1.09)  1.00 (0.89-1.11)  0.99 (0.89-1.09) 
350-499  0.94 (0.85-1.04)  0.97 (0.88-1.08)  0.99 (0.86-1.14)  0.98 (0.88-1.08) 
500+  1.11 (1.01-1.22)  1.15 (1.04-1.27)  1.17 (1.05-1.30)  1.15 (1.04-1.27) 
No CD4 count   0.99 (0.87-1.13)   0.98 (0.86-1.12)   0.98 (0.88-1.10)   0.98 (0.86-1.12) 
1 Virologic failure was defined as first viral load of ≥1,000/mL or 12 months without a viral load test. Hazard ratios and confidence intervals for models with 
only individual- or neighborhood-level variables account for clustering by Census tract, and those with facility-level variables account for clustering by facility 
where suppression was achieved.  Hazard ratios (HR) are unadjusted unless indicated as “AHR.” 
2 Adjusted hazard ratio 1: For each individual-level variable, adjusting for all other individual-level variables 
3 Adjusted hazard ratio 2: For all individual-level variables, adjusting for all facility-level variables 
4 Adjusted hazard ratio 3: For all individual-level variables, adjusting for all neighborhood-level variables 
 
  





Table 3.4. Proportional hazards regressions of HIV virologic failure1 after suppression among persons newly diagnosed 
with HIV in New York City in 2006-2010 and followed through 2012 (N=8,927), by characteristics of the health care facility 
at which persons were diagnosed and the neighborhood (Census tract) persons were living in at diagnosis 
    
HR                                 
(95% CI)1   
AHR 1                      
(95% CI)1,2   
AHR 2                         
(95% CI)1,3   
AHR 3                          
(95% CI)1,4 
Facility-level variables                 
Facility type by patient volume          
Hospital, ≥1,000  1.00  1.00  1.00    
Hospital, <1,000  0.97 (0.87-1.08)  0.98 (0.87-1.11)  0.98 (0.87-1.11)    
Outpatient, ≥1,000  0.56 (0.48-0.65)  0.62 (0.52-0.74)  0.63 (0.53-0.75)    
Outpatient, <1,000  1.17 (1.07-1.28)  1.17 (1.03-1.34)  1.17 (1.03-1.33)    
Private physician, ≥1,000  0.66 (0.50-0.88)  0.84 (0.75-0.94)  0.84 (0.75-0.94)    
Private physician, <1,000  0.81 (0.73-0.89)  0.94 (0.81-1.08)  0.94 (0.81-1.08)    
Other or unknown, <1,000  1.16 (0.92-1.45)  1.26 (1.00-1.59)  1.28 (1.01-1.62)    
Distance between patient and facility          
<1 mile  1.00  1.00  1.00    
1 to <5 miles  0.99 (0.92-1.07)  0.96 (0.89-1.05)  0.98 (0.90-1.07)    
5 to <10 miles  0.91 (0.80-1.02)  0.90 (0.80-1.01)  0.94 (0.85-1.04)    
≥10 miles  1.01 (0.86-1.18)  0.94 (0.80-1.10)  0.96 (0.83-1.11)    
Neighborhood-level variables          
Percent of population below federal poverty 
threshold in past 12 months 
         
Low (<10%)  1.00  1.00    1.00 
Medium (10 to <20%)  1.17 (1.05-1.30)  1.12 (1.00-1.24)    1.11 (0.99-1.23) 
High (20 to <30%)  1.35 (1.21-1.50)  1.19 (1.07-1.33)    1.17 (1.04-1.31) 
Very high (≥30%)  1.49 (1.34-1.64)  1.23 (1.11-1.37)    1.19 (1.06-1.34) 




Percent of population 16 years and over that was 
unemployed in past week5 
 1.22 (1.15-1.30)  1.09 (1.02-1.17)    1.04 (0.96-1.12) 
Percent of population that is black or African 
American only (non-Hispanic)5 
  1.04 (1.03-1.05)   1.01 (1.00-1.02)       1.01 (1.00-1.02) 
1 Virologic failure was defined as first viral load of ≥1,000/mL or 12 months without a viral load test. Hazard ratios and confidence intervals for facility-level 
variables account for clustering by facility where suppression was achieved, and those for neighborhood-level variables account for clustering by Census 
tract.  Hazard ratios (HR) are unadjusted unless indicated as “AHR.” 
2 Adjusted hazard ratio 1: For each facility- or neighborhood-level variable, adjusting for all individual-level variables 
3 Adjusted hazard ratio 2: For all facility-level variables, adjusting for all individual-level and all other facility-level variables 
4 Adjusted hazard ratio 3: For all neighborhood-level variables, adjusting for all individual-level and all other neighborhood-level variables 
5 Hazard ratios presented for continuous variables (percent unemployed and percent black) represent the risk per 10-percentage-point increase in the 
variable. 
 




Figure 3.1. Kaplan-Meier survival curves of maintenance of HIV viral suppression after 
first viral suppression among persons newly diagnosed with HIV in New York City in 
2006-2010 and followed through 2012 
 
Figure 3.1a. By CD4 count (cells/mL) at suppression (p<0.01) 
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Figure 3.1b. By facility type and annual patient volume (number of HIV-positive persons seen by 
facility where first HIV viral suppression occurred, in year of person’s first suppression) (p<0.01) 
 
 
Figure 3.1c. By neighborhood poverty (percent of residents with incomes under the federal 
poverty threshold) (p<0.01) 
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Chapter 4. The association of perceived neighborhood social cohesion with 
achievement of HIV viral suppression among persons recently diagnosed with 
HIV and interviewed in New York City 
Introduction 
New York City (NYC) is home to more than 7% of all persons newly diagnosed with HIV in the 
United States (US) each year.[1, 2]. It is recommended that persons newly diagnosed with HIV have their 
viral load (VL) measured as soon as they begin HIV-related medical care and then at least every six 
months.[3]  Acute HIV infection typically is followed by a very high VL (e.g., >100,000 copies of HIV RNA 
per milliliter of blood) that eventually declines to lower levels that vary by individual.  Further reduction of 
HIV VL to low or undetectable levels (e.g., ≤400 copies/mL) is referred to as viral suppression.  Although 
a small percentage of persons (i.e., “elite controllers”) is able to achieve suppression without treatment, 
most persons achieve suppression through treatment with antiretroviral therapy (ART).[4]  Provided that 
the virus is sensitive to the multi-drug regimen chosen and the person is adherent, suppression is 
achieved quickly (within 24 weeks) and durably.[5, 6] 
Viral suppression not only slows progression of HIV disease [7] but also reduces the likelihood of 
onward sexual transmission.[8]  As few as 20% of PLWHA were thought to be suppressed in the US in 
the early 2000s, while today most estimates exceed 50%;[10-14] in NYC, it was 59% in 2010.[14]  In 
2010, the US National HIV/AIDS Strategy set as a goal a 20% increase by 2015 in the proportion of 
persons in populations most affected by HIV (blacks, Hispanics, and gay and bisexual men) who are 
virally suppressed.[9]  Updated national HIV treatment guidelines now recommend that all persons with 
HIV be offered ART.[3]  However, until recently, it was recommended that persons begin ART only once 
immunocompromised, making immune status the key factor in treatment decisions.  Although retention in 
care and ART are the main drivers of viral suppression, more rapid achievement of suppression has also 
been associated with individual-level demographic characteristics (e.g., older age,[13, 15, 20] male 
sex,[21-23] and non-black racial/ethnic category [13, 24-28]), and baseline clinical status indicators (e.g, 
CD4 count and VL[15, 29, 30]). 
Studies focusing on individual-level factors affecting viral suppression may benefit from the 
addition of social and structural variables that have previously been associated with health and health-
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seeking behavior, such as perceived neighborhood social cohesion.  Lower perceived neighborhood 
social cohesion has been associated with lower primary care use among older urban adults.[44]  Lower 
care use may, in turn, influence the time from HIV diagnosis to viral suppression because ART and VL 
testing are offered exclusively in the context of medical care visits.  Low cohesion has also been 
associated with lower condom use and higher sexually transmitted infection (STI) rates among urban 
adolescents and young adults.[45, 46]  Because STI can increase VL, social cohesion may affect viral 
suppression through condom use and STI rates.  However, the association of social cohesion with HIV 
outcomes has not been examined.  The availability of data on social cohesion for a sample of New 
Yorkers recently diagnosed with HIV allows the investigation of the effect of perceived neighborhood 
social cohesion on achievement of viral suppression among NYC residents who were diagnosed with HIV 
between 2006 and 2012 at ≥13 years of age.  Findings could potentially be helpful in the development of 
interventions to increase suppression rates by accounting for a person’s perception of neighborhood 
social cohesion and determining which persons may need additional support to achieve suppression. 
Methods 
Data sources 
This retrospective analysis used data from the NYC HIV surveillance registry, the NYC arm of the 
CDC-coordinated Case Surveillance-Based Sampling project (CSBS),[53] and the 2007-2011 American 
Community Surveys.[55]  The surveillance registry includes all persons diagnosed and reported with HIV 
in NYC since 2000 and all persons with AIDS since 1981.  It gathers information by medical record 
review, provider report at diagnosis, personal interviews with patients, and HIV-related laboratory tests, 
which are electronically reported to surveillance for all cases receiving diagnosis and/or care in NYC.  
Individual-level data acquired from the registry included demographic and clinical information collected at 
the time of first report, ZIP code of residence at diagnosis, and HIV-related laboratory test results from 
January 1, 2006, to June 30, 2014.  Laboratory reports contain the test type, specimen collection date, 
result, and submitting provider or facility.  Reports on existing cases are added to their registry record; 
reports not matching an existing case are sent out for field investigation to confirm the diagnosis and 
collect other required data.  All registry data used in this analysis were reported as of September 30, 
2014, allowing a three-month reporting lag for laboratory tests performed through June 30, 2014. 
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CSBS was a surveillance activity that involved conducting in-person interviews and medical 
record reviews for a stratified random sample of persons from the registry.  It was a three-year, multisite 
demonstration pilot project coordinated by the CDC.  CSBS used the HIV surveillance system to draw a 
sample of HIV-diagnosed adults that would include persons out of care as well as persons in care.  As of 
2015, the CDC’s Medical Monitoring Project had adopted the CSBS sampling method. 
CSBS data are stored outside of the HIV surveillance registry.  Data from CSBS used for this 
analysis included individual-level information on household income, number of persons who depended on 
that income (a proxy for family size), highest educational level completed, and three questions 
aggregated to develop an index of perceived neighborhood social cohesion, as has been done 
previously.[45, 46]  These CSBS variables were obtained from the interview portion of the 2012-2014 
cycles of the study and recorded in the CSBS database by April 15, 2015. 
Finally, neighborhood poverty statistics at the level of ZIP code tabulation area (ZCTA) were 
acquired from the 2011 American Community Survey 5-year estimates based on the 2007-2011 surveys.  
ZIP codes are a system of delineating areas for postal service, and most people know the ZIP code of 
their residence, while ZCTAs are geographic areas used by the American Community Survey as close 
geographic approximations of ZIP codes.[105]  ZIP codes, which in NYC are typically larger than Census 
tracts but smaller than congressional districts and counties, were the smallest readily available 
geographic unit of analysis.  Neighborhood poverty statistics were linked to cases through the ZIP code of 
patient residence at diagnosis. 
Population 
CSBS sampled 800 persons from the HIV surveillance registry across three annual sample cycles 
(200 persons in the 2012 cycle, 300 in 2013, and 300 in 2014).  Each cycle’s sample was stratified by 
diagnosis year to oversample persons diagnosed in more recent years and limited to persons ≥18 years 
of age as of the sample date.  NYC residents who were interviewed for CSBS in 2012-2014, newly 
diagnosed with HIV between 2006 and 2012, and ≥13 years of age at diagnosis (which was potentially 
several years prior to the sample date) were eligible for the analysis.  However, among the 294 persons 
located and interviewed for CSBS in 2012-2014, many were excluded: those who were not newly 
diagnosed with HIV between 2006 and 2012 and ≥13 years of age at diagnosis (n=152), did not have an 
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NYC ZIP code of residence at diagnosis (n=9), died within 31 days after diagnosis (n=0), did not have a 
Western blot confirmatory test within 31 days post-diagnosis and were not diagnosed during acute HIV 
infection (i.e., their true diagnosis date was uncertain; n=6), had a suppressed (≤400 copies/mL) viral load 
≤31 days after diagnosis (which suggests a misclassified diagnosis date; n=11), or did not respond to all 
three questions about perceived neighborhood social cohesion (n=24).  These exclusions yielded an 
analytical sample of 92 persons (see Appendix 2).  
Outcome 
The outcome of interest was the first suppressed VL (≤400 copies of HIV RNA/mL plasma) after 
HIV diagnosis.  The cut-off was 400 copies/mL because this was the highest lower detectable limit of all 
VL assays in use during the study period.[59]  Persons were censored at death or the end of the follow-up 
period, whichever came earlier.  Follow-up time was calculated as the number of days from the date of 
HIV diagnosis to suppression, death, or 6/30/2014, whichever came first.  There was no minimum 
required follow-up time.  In addition to measuring this outcome as time-to-event, it was also measured 
dichotomously as having or not having achieved suppression within 12 months of diagnosis. 
Treatment guidelines evolved during the analysis period but recommended that VL tests were 
conducted 2-4 times per year after HIV diagnosis.  However, some persons with HIV may have had 
infrequent or no VL tests after diagnosis, because they were never linked to HIV-related medical care, 
they sought care infrequently, or their physician did not test their VL at every care visit.  Any persons not 
known to be dead and with no suppressed VL (including persons with infrequent or no VL tests) were 
presumed not to be suppressed and contributed follow-up time as long as they were alive. 
Independent variable 
Perceived neighborhood social cohesion was calculated from participant agreement with three 
statements in the CSBS interview about trust, closeness, and helpfulness between neighbors, using a 
scored 1-4 Likert scale (see Appendix 8). [45, 46]  Responses were summed to yield a score ranging 
from 3 to 12.  Scores were dichotomized near the median, a natural break, placing approximately 
equivalent numbers of persons in each category.[46]  The majority of scores were 6, 9, or 12 (>20% 
each), and 48% of persons had scores of 3-8 (see Appendix 8 for additional details, including results of 
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our analyses were cohesion to have been classified as a three-level variable).  Perceived neighborhood 
social cohesion was classified as low for persons with scores of 9-12 and high for persons with scores of 
3-8; lower scores indicated agreement with positive statements about the neighborhood. 
Covariates 
Individual characteristics and neighborhood poverty were treated as potential confounders based 
on previous studies.[15, 31, 33]  Demographic characteristics (age, sex at birth, race/ethnicity, country of 
birth), HIV transmission risk (also referred to as transmission category), diagnosis date, viral loads, CD4 
counts, and ZIP code of residence at diagnosis for calculation of neighborhood-level poverty were 
extracted from the NYC HIV surveillance registry.  Estimated poverty status (at the individual/family level, 
based on household income) was calculated from CSBS data. 
Age at HIV diagnosis was calculated from birth date and date of diagnosis and dichotomized as 
13-29 years old and 30+.[2]  Sex at birth was classified as male or female.  Race (white or Caucasian, 
black or African American, Asian or Pacific Islander, and Native American) and ethnicity (Hispanic, non-
Hispanic, or unknown) were collected through two questions and combined into a single variable that was 
dichotomized as: black or Hispanic, and other for those of other race/ethnicity.  Country of birth was 
collected as country of birth when available or region of birth and categorized as born in the US or a US 
dependency (e.g., Puerto Rico), or a foreign country. 
HIV transmission risk category was based on the self-reported pre-diagnosis risk behaviors of the 
case (e.g., injection drug use, male-male sex) and the sex, HIV status (e.g., HIV-positive), and risk (e.g., 
injection drug use) of the pre-diagnosis heterosexual sex partners reported by the person (which could 
indicate high-risk heterosexual risk).[69]  This information was combined into hierarchical, mutually 
exclusive categories for the case: injection drug use (IDU), men who have sex with men (MSM), 
heterosexual sex, and other or unknown (which included perinatal transmission),[15] and these 
categories were then combined into three final groups: MSM, heterosexual, or other or unknown (which 
included injection drug users).  To be classified as a heterosexual male or female, persons must have 
reported pre-diagnosis sex with a partner of the other sex who was HIV-infected, had injected drugs, or 
had received blood products.  In addition, females only could be classified as heterosexual if they had 
probable heterosexual transmission noted in their medical record, reported sex with a male and no history 
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of drug injection, or had any one of several behaviors associated with heterosexual transmission: history 
of prostitution, multiple sex partners, sexually transmitted disease, crack/cocaine use, or sex with a 
bisexual male.[2] 
For analytic purposes, the year of diagnosis was determined from the earlier of physician 
diagnosis date or positive Western blot test result and grouped as 2006-2009 and 2010-2012.  These 
were two approximately equal groups of years divided at a point when suppression became more likely 
for everyone because of new HIV drug approvals and updated guidelines that encouraged earlier 
treatment initiation; also, few CSBS participants (n=6) were diagnosed in 2006 or 2007.  CD4 count (if 
any) at diagnosis (i.e., within 3 months of diagnosis) and year of diagnosis vis-à-vis treatment guidelines 
were used to estimate treatment eligibility and as a proxy for receipt of ART, on the presumption that the 
majority of persons reaching the federal treatment threshold would receive ART.  Treatment-eligible 
persons included those diagnosed in 2006-2007 with CD4<200, diagnosed in 2008-2009 with CD4<350, 
or diagnosed in 2010-2012 with CD4<500, reflecting changing treatment guidelines that increased the 
CD4 count at which ART initiation was recommended.[70-72]  All other persons, including those with no 
reported CD4 counts, were not known to be eligible and were classified as not eligible. 
Analyses included neighborhood-level poverty, defined as percent of residents in a ZIP code with 
incomes under the federal poverty threshold, from 2011 American Community Survey 5-year 
estimates.[74]  We used this source because the 2010 decennial census did not collect poverty 
information, and because ZIP code of residence was collected (by the surveillance registry) at diagnosis.  
For those reasons, the 2011 American Community Survey 5-year estimates had the largest overlap with 
the diagnosis period (2006-2012).  Because lower neighborhood-level socioeconomic status (SES) may 
be associated with both perceived neighborhood social cohesion and viral suppression, it was controlled 
for when exploring the relationship between perceived neighborhood social cohesion and suppression.  
The neighborhood poverty measure that we used has been associated with HIV and STI incidence and 
prevalence and HIV outcomes in the US and Canada.[31, 33, 39, 40, 47, 75]  Neighborhood poverty was 
specified as <20% (i.e., <20% of residents had incomes below the federal poverty threshold; these were 
low- or medium-poverty neighborhoods) or ≥20% (high- or very-high-poverty), based on the four-category 
classification used by the NYC health department that this analysis collapsed into two categories.[76] 
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Estimated poverty status (at the individual/family level) was calculated based on responses in 
CSBS to questions about household income (which was collected in intervals) and number of persons 
who depended on that income.  These were compared with US Census Bureau weighted average 
poverty thresholds for 2013 by size of family unit, and then classified as below the poverty threshold (and 
thus “poor”) or above (“non-poor”) (see Appendix 9 for details).[106] 
Statistical analysis 
Descriptive statistics for selected individual and neighborhood characteristics were calculated and 
presented for the overall population and according to suppression status within 12 months of diagnosis.  
Significance of associations between each variable and achievement of suppression within 12 months 
was assessed using Chi-square tests.  The Mann-Whitney U test was used to ascertain differences in 
median days to suppression by the end of the follow-up period.  The Spearman correlation coefficient was 
obtained to assess whether the dichotomized variable of perceived neighborhood social cohesion and 
neighborhood-level poverty were too correlated (i.e., r>0.5) to be in the same model. 
Kaplan-Meier curves showing the number of days from diagnosis to suppression were generated 
by key individual and neighborhood characteristics, and log-rank tests were used to measure differences 
between groups. 
We used Cox proportional hazards regressions to estimate the association of individual and 
neighborhood factors with suppression in crude and adjusted models.  Because of the small sample size, 
we did not account for correlations of individual outcomes within neighborhood (ZIP code).[62, 63]  
Unadjusted models were fitted to estimate the unadjusted hazards of viral suppression for each individual 
and neighborhood characteristic. In addition, several multivariable models were fitted, striving for 
parsimony given the small sample size.  Our final model included age at HIV diagnosis, sex at birth, 
race/ethnicity, year of HIV diagnosis, and ART eligibility, for consistency with previous models of viral 
suppression,[15] as well as perceived neighborhood social cohesion and neighborhood-level poverty. 
All analyses were conducted using SAS 9.2 (SAS Institute, Cary, NC).  Ethical approval for these 
analyses was provided by the Institutional Review Boards of Lehman College of the City University of 
New York and of the NYC Department of Health and Mental Hygiene. 





Of 92 New Yorkers newly diagnosed with HIV in 2006–2012 and interviewed by CSBS, 
approximately three-quarters were male (72.8%), and black or Hispanic (82.6%; Table 4.1).  More than 
half were ≥30 years old (66.3%), born in the US or a US dependency (68.5%), MSM (51.1%), diagnosed 
in 2010-2012 (54.3%), not eligible to receive treatment based on CD4 count and diagnosis year (53.3%), 
poor (60.9%), perceiving low neighborhood social cohesion (52.2%), and residents of high- or very-high-
poverty neighborhoods (57.6%). 
Sixty-five percent of the population achieved suppression within 12 months of diagnosis (Table 
4.1).  Suppression rates at 12 months were lower among persons who were younger (45.2% of persons 
13-29 years old achieved suppression vs. 75.4% of persons ≥30), black or Hispanic (59.2% vs. 93.8%), 
born in the US or a US dependency (57.1% vs. 82.8%), and not eligible for treatment (46.9% vs. 86.0%; 
all p-values<0.05).  Differences in suppression at 12 months between persons reporting low cohesion 
(60.4%) and high cohesion (70.5%) were not significant (p=0.31). 
Almost the entire population (95.7%) achieved viral suppression by 6/30/2014 (not shown), in a 
median of 180 days (Table 4.1).  Suppression happened least quickly among persons who were younger 
(median=377 days), black or Hispanic (203 days), born in the US or a US dependency (218 days), not 
known to be eligible for treatment (372 days), or who had low perceived neighborhood social cohesion 
(204 days; all p-values <0.05).  Differences were most prominent by age (median=164 days among 
persons ≥30 years old vs. 377 days among 13-29) and treatment eligibility (159 days among eligible vs. 
372 days among not eligible).  Kaplan-Meier survival curves demonstrated the lack of difference in 
achievement of suppression between persons with low and high perceived neighborhood social cohesion 
(p=0.95; Figure 4.1a), the difference between persons eligible and not eligible for treatment (p<0.01; 
Figure 4.1b), and the lack of difference between residents of high- or very-high-poverty vs. low- or 
medium-poverty neighborhoods (p=0.46; Figure 4.1c). 
The Spearman correlation coefficient between perceived neighborhood social cohesion and 
neighborhood-level poverty was 0.24 (analysis not shown in tables), indicating a low correlation, and thus, 
suggesting that they capture independent constructs. 
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Unadjusted and adjusted models 
Table 4.2 presents the unadjusted and adjusted HRs for HIV viral suppression among CSBS 
participants newly diagnosed with HIV in NYC.  The unadjusted HRs show that perceived neighborhood 
social cohesion was not associated with suppression.  Persons who were black or Hispanic, born in the 
US or a US dependency, diagnosed in 2006-2009, or not eligible for treatment were at least 42% less 
likely to achieve viral suppression (range 42% to 60%) than others.   
Multivariable regression included perceived neighborhood social cohesion, age at HIV diagnosis, 
sex at birth, race/ethnicity, year of HIV diagnosis, ART eligibility, and neighborhood-level poverty.  
Perceived neighborhood social cohesion was not associated with suppression in the fully adjusted model, 
nor were year of diagnosis or neighborhood-level poverty, which were among the potential confounders 
included.  The likelihood of viral suppression was 55% lower for blacks or Hispanics (95%CI=0.23-0.86) 
than persons of another race/ethnicity, and 42% lower among persons not eligible for treatment 
(95%CI=0.35-0.96) than treatment-eligible persons, after adjustment.  Compared with a model with 
variables for age at HIV diagnosis, sex at birth, race/ethnicity, year of HIV diagnosis, treatment eligibility, 
and neighborhood-level poverty, this model which added cohesion did not have significantly better fit (-
2LL: 618.149; p=0.3372; see Appendix 10). 
It is worth noting that these adjusted results for social cohesion remained similar when using a 
three-level rather than dichotomous variable (see Appendix 8). 
Discussion 
Controlling for individual characteristics and neighborhood poverty, perceived neighborhood 
social cohesion did not influence the time from HIV diagnosis to viral suppression.  However, persons 
who were black or Hispanic and who were not eligible for treatment were less likely to achieve HIV viral 
suppression after diagnosis. 
Our findings were not consistent with previous studies that have found a relationship between 
perceived neighborhood social cohesion and care-seeking behavior or STI outcomes.[44-46]  Our study 
may have been underpowered to detect an effect of cohesion on suppression.  However, it is also 
possible that cohesion is not associated with condom use, STIs, and care-seeking behaviors among 
persons with HIV in NYC, or that other factors may prevent social cohesion from influencing time to 
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suppression.  For example, the system of care and services, benefits, and large HIV-positive population 
in NYC make it a relatively attractive place for HIV-positive persons to live and receive care.  These 
factors may affect the time to suppression regardless of neighborhood cohesion. 
Findings about race/ethnicity and treatment eligibility were consistent with a previous study using 
NYC HIV surveillance data.[15]  Treatment eligibility and suppression were associated with each other 
presumably because treatment-eligible persons were more likely to have been prescribed ART, almost 
the exclusive means of lowering viral load.  However, our findings on poverty were not consistent with 
previous studies; neighborhood-level socioeconomic factors have been associated with HIV diagnosis 
rates and some care-related outcomes in NYC and elsewhere.[31, 33, 38-42]  Possible explanations for 
this inconsistency include: different outcomes (e.g., time from ART initiation to suppression vs. time from 
diagnosis to suppression); different settings (e.g., Canada vs. US, or other US areas vs. NYC); HIV care 
is perhaps comparably accessible and effective regardless of characteristics of the NYC neighborhood in 
which people live, mitigating neighborhood-level disadvantage after diagnosis; and publication bias may 
have limited the publication of previous null findings on neighborhood characteristics and HIV 
outcomes.[82, 83] 
Limitations 
As in any population-based analysis of HIV care, ours had VL data only when persons sought 
care, which was at their discretion.  Persons in this analysis were not necessarily tested at regular 
intervals.  Persons may have achieved suppression sometime before it was measured in a VL test.  It is 
not clear whether these circumstances would have biased our hazard ratios.  However, all persons in the 
analysis had at least one VL test between 8 days post-diagnosis and censoring.  Persons diagnosed in 
2009, for example, had a median of 13 VL tests (IQR: 7-17), and the median interval between tests was 
140 days (<5 months; IQR: 106-264 days).  Persons diagnosed in 2012 had a median of 8 tests (IQR: 6-
10) and the median interval between tests was 85 days (<3 months; IQR: 67-98 days).  These statistics 
indicate that the majority of New Yorkers recently diagnosed with HIV and interviewed by CSBS were 
engaged in care at intervals that were both consistent with federal guidelines and sufficiently frequent to 
produce estimates of suppression.  Thus, it is unlikely that the lack of regular testing would have 
influenced our results. 
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Persons in this analysis were interviewed by CSBS, numbered fewer than 100 (n=92), and nearly 
universally achieved suppression by the end of the follow-up period.  That these persons could be found 
in NYC and were sufficiently available for an interview suggests that they may differ from other recently 
diagnosed and reported New Yorkers, i.e., they may be more likely to still be living in NYC, be in care, 
and achieve suppression, although it is unclear whether this might affect the relationship between 
cohesion and suppression.  Similarly, analyses of persons with HIV in NYC (who were not necessarily 
recently diagnosed, unlike our analysis population) found that many reported to surveillance appeared to 
no longer live in NYC, and when those were excluded, the rates of care were higher.[14] 
This analysis was conducted with a small population considering the numerous factors we sought 
to control for in multivariable analysis, and the study may have been underpowered.  A post-hoc power 
calculation found that this study had only a 17% chance of rejecting the null hypothesis (i.e., no difference 
in suppression by perceived neighborhood social cohesion level).[107]  It may also be that persons 
certainly in NYC (in this analysis, indicated by having been interviewed by CSBS) have high rates of 
suppression and that differences by subgroups are relatively small, offering an alternative explanation of 
why only a few characteristics were significantly associated with suppression.  A previous study of newly 
diagnosed persons who, according to surveillance records, appeared never to have entered HIV care 
found that three times as many of these persons reported that they were in fact in care as the number 
who agreed that they were out of care.[108]  With near-universal care engagement among persons 
completing CSBS interviews, subgroup differences in suppression may indeed be minor, supporting our 
findings that few factors measured by surveillance or the CSBS interview instrument were associated with 
suppression. 
There are several steps between diagnosis and suppression in the continuum of care for HIV-
positive persons.[10, 13]  By design, this analysis did not elucidate the exact step(s) at which the factors 
measured affect suppression.  This means that the associations that we found exist for the overall 
process from diagnosis to suppression but not necessarily for individual steps between them.  For 
example, cohesion may not influence time from diagnosis to linkage of care but rather only time from 
linkage to suppression. 




This is the first analysis to investigate the influence of perceived neighborhood social cohesion on 
HIV outcomes, and among the first US analyses to use surveillance data to investigate the role of 
neighborhood factors on HIV outcomes. [31, 33, 35, 45, 46, 87]  The data were drawn from the 
population-based HIV surveillance system of the city with largest HIV epidemic in the US, including only 
persons confirmed (by locating them at an NYC address) to still be in the jurisdiction.  Data from multiple 
sources were used to assess the potential influence on viral suppression of factors beyond the individual.  
Mandatory electronic reporting of laboratory tests in NYC provided information about all measured VLs for 
all HIV-positive persons receiving care in NYC, as opposed to in a clinical trials environment, where 
findings can differ from those in a population setting. 
Conclusions 
New Yorkers recently diagnosed with HIV, confirmed to be in NYC, and available for interview 
have almost universally achieved viral suppression.  Being non-black or non-Hispanic and eligible for 
ART was associated with faster viral suppression after diagnosis, presumably leading to improved health 
and preventing ongoing HIV transmission.  In contrast, individuals with characteristics associated with 
slower achievement of suppression may need more assistance after diagnosis with linkage to and 
retention in care or acquiring and adhering to ART.  For example, black and Hispanic persons may 
benefit from more-frequent medical care and prescription of ART, including equitable prescribing behavior 
and/or better adherence support.[92]  These changes may have the potential to raise suppression rates 
among blacks and Hispanics to levels that are comparable to those among whites.[15, 22, 25-27, 91]  
The racial/ethnic disparity in viral suppression was not related to estimated poverty status nor 
neighborhood poverty.  Since 2010, New York State law has required all providers to link positive patients 
to care, and the United States Department of Health and Human Services now encourages antiretroviral 
therapy for all diagnosed persons, regardless of CD4 count, which should further the improvement in 
suppression rates.  Future studies should explore the extent to which persons who can be located for a 
CSBS interview are representative of persons with HIV in NYC. 
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Table 4.1. Achievement of HIV viral suppression among a stratified random sample of persons newly diagnosed with HIV 
in New York City in 2006-2012 who were interviewed and followed through June 2014 





months   
Virologically suppressed within 12 
months   
Median time from 
diagnosis to 
suppression 








Total 100.0 (92)   100.0 (32)   100.0 (60) 65.2    180 (307)   
Perceived neighborhood social 
cohesion 
      
0.3126 
  0.0194 
Low cohesion 52.2 (48)  59.4 (19)  48.3 (29) 60.4   204 (435)   
High cohesion 47.8 (44)  40.6 (13)  51.7 (31) 70.5   168 (234)   
Age group (years) at diagnosis       0.0040   0.0017 
13 - 29 33.7 (31)  53.1 (17)  23.3 (14) 45.2   377 (600)   
≥30 66.3 (61)  46.9 (15)  76.7 (46) 75.4   164 (138)   
Sex at birth       0.8810   1.0000 
Male 72.8 (67)  71.9 (23)  73.3 (44) 65.7   180 (366)   
Female 27.2 (25)  28.1 (9)  26.7 (16) 64.0   189 (323)   
Race/Ethnicity       0.0085   0.0060 
Black or Hispanic 82.6 (76)  96.9 (31)  75.0 (45) 59.2   203 (390)   
Another race/ethnicity 17.4 (16)  3.1 (1)  25.0 (15) 93.8   136 (99)   
Country of birth       0.0165   0.0003 
US or US dependency 68.5 (63)  84.4 (27)  60.0 (36) 57.1   218 (428)   
Foreign 31.5 (29)  15.6 (5)  40.0 (24) 82.8   135 (84)   
HIV transmission risk       0.2998   0.5434 
Men who have sex with men 51.1 (47)  53.1 (17)  50.0 (30) 63.8   186 (293)   
Heterosexual 31.5 (29)  37.5 (12)  28.3 (17) 58.6   210 (352)   
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Other or unknown 17.4 (16)  9.4 (3)  21.7 (13) 81.3   168 (105)   
Year of HIV diagnosis       0.0536   0.2015 
2006 – 2009 45.7 (42)  59.4 (19)  38.3 (23) 54.8   200 (768)   
2010 – 2012 54.3 (50)  40.6 (13)  61.7 (37) 74.0   171 (203)   
Eligible for treatment       <0.0001   0.0057 
Yes 46.7 (43)  18.8 (6)  61.7 (37) 86.0   159 (119)   
No 53.3 (49)  81.3 (26)  38.3 (23) 46.9   372 (735)   
Estimated poverty status       0.5073   0.1915 
Non-poor 39.1 (36)  43.8 (14)  36.7 (22) 61.1   201 (297)   
Poor 60.9 (56)  56.3 (18)  63.3 (38) 67.9   173 (320)   
Percent of population below 
federal poverty threshold in 
past 12 months 
      
0.2558 
  0.0869 
Low or medium (<20%) 42.4 (39)  34.4 (11)  46.7 (28) 71.8   171 (312)   
High or very high (≥20%) 57.6 (53)  65.6 (21)  53.3 (32) 60.4   199 (308)   
                      
1 p-value: Chi-square or (when cells had expected counts <5) Fisher's exact test of association between each variable and achievement of suppression 
2 IQR: Interquartile range, i.e., 3rd quartile minus 1st quartile 
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Table 4.2. Proportional hazards regressions of HIV viral suppression 
among a stratified random sample of persons newly diagnosed with 
HIV in New York City in 2006-2012 who were interviewed and 
followed through June 2014 
    
HR1                                 
(95% CI)   
AHR2                           
(95% CI)   
Perceived neighborhood social 
cohesion      
Low cohesion  1.00  1.00  
High cohesion  0.99 (0.64-1.51)  0.79 (0.49-1.28)  
Age group (years) at diagnosis      
13 - 29  0.69 (0.44-1.08)  0.64 (0.38-1.09)  
≥30  1.00  1.00  
Sex at birth      
Male  0.93 (0.58-1.50)  0.95 (0.57-1.60)  
Female  1.00  1.00  
Race/Ethnicity      
Black or Hispanic  0.40 (0.23-0.69)  0.45 (0.23-0.86)  
Another race/ethnicity  1.00  1.00  
Country of birth      
US or US dependency  0.48 (0.30-0.77)    
Foreign  1.00    
HIV transmission risk      
Men who have sex with men  0.94 (0.58-1.50)    
Heterosexual  1.00    
Other or unknown  1.19 (0.63-2.24)    
Year of HIV diagnosis      
2009 - 2009  0.58 (0.37-0.91)  0.63 (0.38-1.05)  
2010 - 2012  1.00  1.00  
Eligible for treatment      
Yes  1.00  1.00  
No  0.45 (0.29-0.70)  0.58 (0.35-0.96)  
Estimated poverty status      
Non-poor  0.80 (0.52-1.24)    
Poor  1.00    
Percent of population below 
federal poverty threshold in 
past 12 months      
Low or medium (<20%)  1.00  1.00  
High or very high (≥20%)   0.61 (0.28-1.34)   1.00 (0.98-1.02)   
1 HR: Hazard ratio; CI: confidence interval   
2 AHR: Adjusted hazard ratio      
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Figure 4.1. Kaplan-Meier survival curves of time from HIV diagnosis to viral suppression 
among a stratified random sample of persons newly diagnosed with HIV in New York City 
in 2006-2012 who were interviewed and followed through June 2014 
 


































































      
75 
 
Figure 4.1b. By eligibility for antiretroviral therapy (ART) at diagnosis (p<0.01) 
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Chapter 5. Discussion 
Overview 
We measured the association of individual, facility, and neighborhood characteristics with the 
achievement and maintenance of HIV viral suppression among NYC residents diagnosed with HIV 
between 2006 and 2012.  The dates of HIV diagnosis, viral suppression, and virologic failure were 
assessed using the NYC HIV surveillance registry, which included all persons diagnosed or receiving 
care in NYC as well as electronic reports of all of their subsequent viral load tests in NYC.  Facility-level 
characteristics were obtained from the registry and based on facility of diagnosis or of first suppression. 
Finally, neighborhood-level characteristics were acquired from the US Census and American Community 
Survey based on Census tract or ZIP code of residence.  The association of perceived neighborhood 
social cohesion with suppression was assessed for recently diagnosed New Yorkers interviewed by 
CSBS.  For each analysis, the distribution of characteristics in the analytic population, the proportion 
achieving the outcome of interest within 12 months, and the median time to the outcome were presented.  
Kaplan-Meier curves were generated and log-rank tests performed to test for differences between 
subgroups in the likelihood of suppression.  Then multivariable proportional hazards regressions were 
fitted to assess the likelihood of suppression or failure by individual, facility, and neighborhood 
characteristics, accounting for clustering of outcomes by facility or neighborhood whenever the sample 
size allowed it.  Main findings and interpretations are reviewed in the following section. 
Summary of findings 
Chapter 2 
This chapter assessed the association of individual, facility, and neighborhood factors associated 
with achievement of viral suppression after diagnosis among New Yorkers newly diagnosed with HIV in 
2006-2010 (Aim 1).  Of 12,547 New Yorkers newly diagnosed with HIV in 2006–2010, approximately 
three-quarters were 20-49 years old (78.7%), male (74.2%), and black or Hispanic (81.5%); and almost 
one-third were eligible to receive treatment based on CD4 and diagnosis year (30.6%).  Forty-four 
percent of the population achieved suppression within 12 months of diagnosis, with a median time to 
suppression of 245 days.  Suppression was achieved most slowly among persons who were younger, 
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diagnosed in earlier years, not known to be eligible for treatment, and diagnosed at non-hospital facilities 
and facilities farther from the patient’s residence. 
In proportional hazards models adjusting for individual and facility or neighborhood 
characteristics, we observed that persons 13-49 years old, men, blacks and Hispanics, US-born, 
heterosexuals, persons diagnosed in 2006 and 2008 were less likely to achieve suppression than those 
60 and older, women, whites, foreign-born, MSM, and persons diagnosed in 2010, respectively.  This was 
also observed for persons not eligible for treatment vs. treatment-eligible persons, and persons 
diagnosed at facilities that diagnosed 10-74 patients per year vs. facilities that diagnosed  ≥75 patients 
per year, that were screening/diagnosis/referral sites vs. hospitals, or that were <1 mile from the patient 
vs. 1 to <5 miles.  Neighborhood-level poverty, unemployment, and percent black residents were not 
associated with suppression. 
Chapter 3 
This chapter used the subset of persons from the previous aim’s analytical sample who achieved 
viral suppression to assess the individual, facility, and neighborhood factors associated with maintenance 
of viral suppression (Aim 2).  Of 8,927 New Yorkers newly diagnosed with HIV in 2006–2010 who 
achieved viral suppression, almost one-fifth (18.2%) experienced failure within 12 months of suppression 
with an overall median time to failure of 728 days, i.e., about two years after first suppression. 
Adjusting for individual and facility or neighborhood characteristics, proportional hazards models 
show the following groups to be the least likely to maintain suppression: younger persons (<50 years old 
vs. ≥60), blacks and Hispanics, US- and US-dependency born persons, heterosexuals and injection drug 
users, persons with CD4 counts ≥500 cells/mL at suppression, persons receiving care at facilities that 
were not large outpatient facilities or large private practices, and residents of high- or very-high-poverty 
neighborhoods. 
Chapter 4 
This chapter assessed individual and neighborhood factors, particularly perceived neighborhood 
social cohesion, associated with achievement of viral suppression after diagnosis, among a sample of 
New Yorkers newly diagnosed with HIV in 2006-2012 (Aim 3).  Out of 92 New Yorkers newly diagnosed 
      
78 
 
with HIV in 2006–2012 and interviewed by CSBS, 65% achieved suppression within 12 months of 
diagnosis.  Almost the entire population (95.7%) achieved viral suppression by the end of the follow-up 
period on June 30, 2014, with a median of 180 days.  Kaplan-Meier curves indicated no difference in time 
to suppression by perceived neighborhood social cohesion.  In regression adjusting for age at HIV 
diagnosis, sex at birth, race/ethnicity, year of HIV diagnosis, ART eligibility, and neighborhood poverty, 
perceived neighborhood social cohesion was not associated with suppression. 
Limitations 
As in any population-based analyses of HIV care, ours had VL data only when persons sought 
care, which was at their discretion.  Persons in our analyses were not necessarily tested at regular 
intervals.  Thus, they may have achieved suppression or failure sometime before it was measured in a VL 
test.  It is not clear whether these circumstances would have biased our hazard ratios.  However, the 
majority of New Yorkers newly diagnosed with HIV between 2006 and 2012 were in fact engaged in care 
as frequently as was recommended by federal guidelines. 
Persons not receiving care in NYC were presumed to be present and unsuppressed (in the 
analyses of time to suppression) or maintaining suppression for 12 months (in the analysis of time to 
failure), although they may have moved out of NYC and become suppressed or experienced failure 
elsewhere.  Non-ascertainment of outmigration is a typical limitation of local HIV surveillance data and 
may be differential across subgroups. For example, if outmigration happened more frequently among 
men, which has been reported previously,[85] this could exacerbate the male-female disparity in 
suppression rates. 
For the Aim 3 analysis, the analytical sample was fewer than 100 and with higher suppression 
rates than newly diagnosed persons citywide.  We were underpowered to detect a difference in 
suppression between persons perceiving low vs. high neighborhood social cohesion.  That these persons 
could be found and interviewed suggests that they may have higher rates of care than other newly 
diagnosed New Yorkers.[14]  However, they may not necessarily have different predictors of suppression 
otherwise.  A previous analysis of all NYC residents newly diagnosed with HIV found younger age and 
earlier year of diagnosis to be associated with delayed suppression.[15, 109]  Alternatively, it may be that 
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persons certainly in NYC (such as CSBS participants) have high rates of suppression and that differences 
between subgroups are relatively small. 
There are several steps between diagnosis and suppression in the “care continuum” for HIV-
positive persons.[10, 13]  By design, our analyses did not elucidate the exact step(s) of the continuum – 
diagnosis, linkage to care, retention in care, provision of ART, or viral suppression – at which the 
characteristics studied affect suppression. 
Strengths and public health significance 
These are among the first analyses in the US to investigate the influence of facility and 
neighborhood, and the first to assess the influence of perceived neighborhood cohesion, on HIV 
outcomes using surveillance data,[31, 33, 35, 45, 46, 87]  The data were drawn from population 
surveillance in a diverse city with the largest HIV epidemic in the US.  Analyses combined data from 
multiple sources to assess the potential influence on the achievement and maintenance of viral 
suppression of factors beyond the individual.  Mandatory electronic reporting of laboratory tests in NYC 
provided information about all measured VLs for all HIV-positive persons receiving care in NYC, as 
opposed to in a clinical trials environment, where findings can differ from those in a population setting.  
This makes our results generalizable to the population of NYC residents with HIV.  To assign area-based 
characteristics to individuals, we used, whenever available, patient address geocoded to the Census 
tract, which is the gold standard for detection of public health disparities.[47]  Aim 3 data included only 
persons confirmed (by locating them at an NYC address) to still be in the jurisdiction.  This ensures that 
factors found to be associated with suppression are truly that, and not simply proxies for continued 
residence in NYC. 
Policy recommendations and future research directions 
We have identified individual, facility, and neighborhood characteristics that seem to help persons 
newly diagnosed with HIV to achieve and maintain viral suppression, and thus, improve their health and 
prevent ongoing HIV transmission.  These individuals, health care facilities, or neighborhoods with 
characteristics associated with slower achievement of suppression may need more assistance with post-
diagnosis linkage to and retention in care, ART prescribing, or adherence.  Such supports might include 
      
80 
 
care coordination, case management, behavioral counseling, strategic planning about the locations of 
facilities, or additional training for physicians.  Below we describe the implications of our findings in each 
of these arenas in more detail as well as revisit the issue of study design and interviews of persons with 
HIV.  Our findings may be valuable to agencies planning testing programs, medical care for individuals 
with HIV, and “prevention with positives” programs. The agencies may wish to evaluate their effectiveness 
with these populations and/or expand their scope to reach most-affected groups or neighborhoods.  Our 
findings may also help strengthen existing programs that appear to be working, such as the NYC care 
coordination program and housing services,[66, 67] or help explain why others may not work.  For 
example, they may wish to place additional focus on individuals, facilities, or neighborhoods with 
characteristics associated with poorer achievement or maintenance of suppression; or review programs 
that help patients achieve relatively high rates of good outcomes in spite of challenges (i.e., serving 
persons who typically have poorer outcomes), as potential examples of best practices. 
Individual characteristics 
Several individual characteristics had previously been found to be associated with the 
achievement and maintenance of suppression,[15, 20, 21] and our adjusted analyses confirmed these 
associations.  For example, persons who were older, white, foreign-born, diagnosed in later years, MSM, 
and eligible for ART were more likely to achieve and maintain suppression.  Changing treatment 
guidelines favoring universal consideration of ART initiation will likely minimize the association of CD4 
count (and somewhat, by extension, age) with suppression, but disparities by stage of illness and other 
factors, such as demographics, may remain.  For example, black persons need better HIV-related care 
and/or support that permits them to receive optimal ART regimens and achieve and maintain suppression 
at comparable rates as whites;[15, 22, 25-27, 91] rectifying this disparity, which Chapter 4 suggested was 
related to individual race/ethnicity and not individual poverty status, neighborhood poverty, or 
neighborhood racial composition, may require more equitable prescribing behavior and/or better 
adherence support.[92] 
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Health care facility characteristics 
We found a few associations between distance from a person’s residence to their health care 
facility and achievement and maintenance of suppression.  The extensiveness of NYC’s systems of HIV 
care and public transportation,[97] coupled with New York State’s generous benefits and services for 
persons with HIV,[98] may have helped minimize the impact of patient-provider distance on virologic 
suppression failure. 
NYC can continue to encourage HIV testing at large facilities, including hospitals, where patients 
have the greatest likelihood of reaching suppression quickly.  We can also increase the technical capacity 
of certain types of facilities, namely those that make fewer diagnoses annually, or that are neither 
hospitals nor private physicians’ offices.  These types of facilities need to do a better job at moving their 
patients along the continuum of care from diagnosis to suppression.  An alternative solution may be 
ensuring effective linkage to care at a different type of site, such as one that has cared for more HIV-
positive patients.  Health care facilities where patients have better achievement and maintenance of 
suppression could be examined for their “best practices” and these practices considered either for scale-
up across facilities or as recommendations of which types of facilities have the potential to provide the 
best care. 
Several developments are encouraging all New Yorkers diagnosed with HIV to move along the 
continuum of care.  Since 2010, New York State law has required all providers to link HIV-positive 
patients to care.[110]  The United States Department of Health and Human Services now encourages 
antiretroviral therapy for all diagnosed persons, regardless of CD4 count.[3]  Both sets of guidelines 
should further the improvement in suppression rates.  Future studies should monitor whether facility-level 
disparities in suppression decrease over time, as more facilities presumably adhere to the law. 
Neighborhood characteristics 
We found that neighborhood-level poverty influences maintenance of suppression but not 
achievement of suppression.  This suggests that the many resources available for low-income PLWHA in 
NYC to receive care, medication, and other forms of support may reduce but not entirely eliminate the 
negative effects of poverty on HIV-related health outcomes.  It is possible that the effects of 
neighborhood-level poverty would have been even larger in a setting other than NYC that may not have 
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been as well-resourced vis-à-vis medical facilities and transportation system.  Still, rectifying the disparity 
in maintenance of suppression between residents of poorer and wealthier neighborhoods may require 
targeted adherence support services or additional general poverty alleviation, including increased units of 
subsidized and/or supportive housing. 
Study design 
We found near-universal care engagement and viral suppression among persons completing 
CSBS interviews, while figures among newly diagnosed PLWH overall were more modest.  Future studies 
should explore the extent to which persons who can be located for an interview are representative of 
persons with HIV in NYC. 
Conclusions 
Our analyses are among the first in the US to reveal facility and neighborhood characteristics 
associated with achievement and maintenance of viral suppression among persons newly diagnosed with 
HIV.  We confirm that several individual characteristics appear to also influence suppression, but 
perceived neighborhood social cohesion may not.  We rely on population surveillance and interviews of 
persons sampled from surveillance, and matched both with US Census Bureau data to obtain information 
on neighborhood-level characteristics.  Our results from Aims 1 and 2 are generalizable to the population 
of persons living with HIV in NYC, and further exploration of the representativeness of persons with HIV 
who can be located for an interview would be valuable.  Increases in post-diagnosis linkage to and 
retention in care, and receipt of and adherence to ART, that reach groups of persons, patients at facilities, 
or residents of neighborhoods that we found to have poorer outcomes, may improve the achievement and 
maintenance of viral suppression in NYC. 
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Appendix 1. Populations for analyses of achievement (Aim 1) and maintenance 
(Aim 2) of HIV viral suppression among newly diagnosed New Yorkers 
 
20,285 persons diagnosed 2006-2010, per latest registry dataset  
20,225 persons 13+ years old at diagnosis, per latest registry dataset 
17,825 NYC residents, per latest registry dataset                                                                                 
        15,265 had XY coordinates of address of residence at diagnosis and were geocoded to census tract 
based on XY coordinates 
15,084 had non-missing census tract-level variables 
15,059 had non-missing facility of diagnosis 
14,588 had non-zero distance from residence at diagnosis to facility of diagnosis  
(eliminate homeless and some institutionalized persons, whose residence is set to facility address) 
14,336 were not diagnosed at a correctional facility  
 
14,116 had no death date or it occurred at least 31 days after diagnosis  
(eliminate persons with pre-diagnosis death or death in first month) 
 
13,400 had a Western blot (confirmatory test) within 31 days post-diagnosis or were an acute HIV 
infection 
(eliminate persons likely to have misclassified diagnosis date) 
 
13,399 did not have a detectable (>50 copies/mL) viral load >31 days prior to diagnosis or were an acute 
HIV infection 
(eliminate persons likely to have misclassified diagnosis date) 
 
12,547 did not have a suppressed (≤400 copies/mL) viral load ≤31 days after diagnosis 
(eliminate persons likely to have misclassified diagnosis date) 
 
9,459 ever achieved viral suppression ≥31 days after diagnosis 
 
9,135 achieved suppression by end of follow-up (12/31/2012) 
 
9,132 had no death date or it occurred after suppression 
(eliminate persons with pre-suppression death) 
 
9,125 had non-missing facility of suppression 
8,993 had non-zero distance from residence at diagnosis to facility of suppression  
(eliminate homeless and some institutionalized persons, whose residence is set to facility address) 
8,927 were not suppressed at a correctional or screening/diagnostic facility  
Population 
for Aim 1 
Population 
for Aim 2 
      
84 
 
Appendix 2. Population for analysis of HIV viral suppression among recently 
diagnosed and interviewed New Yorkers (Aim 3) 
298 persons sampled from HIV surveillance registry for Case Surveillance-Based Sampling project 
294 unique persons after removal of duplicates 
 142 persons diagnosed in 2006-2012 and 13+ years old at diagnosis, per latest registry dataset 
 134 NYC residents, per latest registry dataset                                                                                 
        133 have ZIP code of address of residence at diagnosis 
133 had non-missing ZIP-level variables from ACS/Census 
133 had no death date or it occurred at least 31 days after diagnosis  
(eliminate persons with pre-diagnosis death or death in first month) 
 
127 had a Western blot (confirmatory test) within 31 days post-diagnosis or were an acute HIV infection 
(eliminate persons likely to have misclassified diagnosis date; was 5% loss at this step for Aim 1) 
 
127 did not have a detectable (>50 copies/mL) viral load >31 days prior to diagnosis or were an acute 
HIV infection 
(eliminate persons likely to have misclassified diagnosis date) 
 
116 did not have a suppressed (≤400 copies/mL) viral load ≤31 days after diagnosis 
(eliminate persons likely to have misclassified diagnosis date) 
 
92 had responses to all three questions about perceived neighborhood social cohesion 
 
88 ever achieved viral suppression ≥31 days after diagnosis 
 
88 achieved suppression by end of follow-up (6/30/2014) 
(FYI: 60 of them achieved suppression within 12 months) 
 
88 had no death date or it occurred after suppression 
(eliminate persons with pre-suppression death) 
Population 
for Aim 3 
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Appendix 3. Creating a dataset of individual, neighborhood, and facility 
characteristics, January – May 2014 
January 16 and 17, 2014 – Preparing individual-level dataset; reading in area-level variables 
SAS 
Added correctional variables, individual-level variables, first VL, first CD4, and provider XY coordinates.  
They are in a single completed SAS program and saved in a permanent SAS dataset called 
IndivSurvDataForGCCases_20140117.  “GCCases” refers to geocoded cases. 
Began a SAS program to read in and combine area-level datasets.  Read in all ACS datasets and need to 
refer to Excel list at home of neighborhood-level variables, since some ACS datasets have hundreds of 
variables and the Excel list identifies the exact variable needed.  Not all datasets have the same format 
for the geographic variables describing CT, so those will need to be made into the same format before 
merging. 
Outcome 
Finalized dataset with individual-level variables.  Need to continue reading in and combining area-level 
variables.  Have patient and provider XY coordinates and at some point need to do network analysis to 
calculate distance between them. 
January 21, 2014 – Compiling area-level variables 
SAS 
Continued SAS program to read in and combine area-level datasets.  Read in all needed CT-level ACS 
and Census data.  Compared poverty datasets from ACS downloads done by borough and for NYC 
overall, and CT-level poverty stats between the two appeared to be a perfect match, which was 
reassuring.  Converted all percentages into the same format (e.g., xx.x), since some were formatted as 
xx.x%, and formatted geographic info the same across datasets (as GEO_display_label in ACS was 
formatted) so they can be merged.  Apparently there are 2,168 Census tracts in NYC with population 
data; this is the number of observations in the final area-level dataset. 
January 23, 2014 – Creating permanent dataset of area-level variables 
SAS 
Finished program for CT-level data and saved permanent copy. 
BES/DTF slides from approx. 1/16/2014 on combined/split CTs and ZIPs suggest that one ZIP perhaps 
should be combined with another. 
January 28-30, 2014 – Creating facility-level variables, adding Aim 2 maintenance/failure variables, 
combining datasets across levels 
SAS 
Wrote code to determine number of cases diagnosed per provider per year (hars_name, hivdxdtafter year 
in harsoct13sm dataset for 2005-2010), number of unique patients seen per provider per year 
(hars_name, eventdate year of CD4/VL in vlcd4wbprovoct13 dataset for 2005-2010), and facility type 
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(provider and providercode in pv_provider dataset as of 1/30/2014, and DACs per NYS and NYC lists 
from 1/2006 – 2013).  Saved datasets. 
Revisited SAS program for individual-level data to add variables for Aim 2, e.g., 1st CD4 within 1 month 
before or after 1st suppressed VL, provider at 1st suppressed VL, and maintenance of suppression (i.e., 
failure per VL >400 or >1,000 or >366 days without a test). 
Began SAS code to combine individual, neighborhood, and facility-level datasets. 
January 31 and February 3-4, 2014 – Completing dataset for Aims 1 and 2, ruling out possibility of 
patient-provider XY distance network analysis 
SAS 
Checked the completeness of care patient load (FirstSuppVLProv by year of FirstSuppVLDate) and many 
were missing.  Realized that the care patient load count by provider was only through 2010, so I reran 
that through the latest year of care data (2013) and recombined facility-level data with the individual-level 
dataset. 
Reviewed provider XY coordinate availability and discovered that about one-third of patients that we’d 
want to have it (they were diagnosed in 2006-2010 and have a non-missing diagnosing provider) did not 
have provider XY coordinates.  Looked at frequency of diagnosing providers (hars_name) with missing 
XY and found that numerous major providers had not been geocoded to XY coordinates.  Network 
analysis does not seem possible without a major geocoding effort for providers. 
Added dthdate (patient death date) to list of variables pulled from registry dataset, in order to calculate 
censor date. 
Calculated censor dates, time from diagnosis or suppression to censoring, and whether censoring was 
due to the outcome of interest (suppression for Aim 1, failure for Aim 2).  Censoring variables for Aim 2 
are available at VL>400 and VL>1,000. 
Completed SAS code to combine individual, neighborhood, and facility-level datasets. 
February 5, 2014 – Reviewing variables and population, and adding hboro 
SAS 
Read in combined indiv/neighb/facility dataset and reviewed most variables with freqs and measures of 
central tendency.  All (individual and neighborhood) look okay so far – need to check provider and 
outcome variables still. 
Added hboro to datasets, to be able to specify the population as persons living in NYC at diagnosed. 
April 15, 2014 – Expanding provider characteristics 
SAS 
Created SAS program to calculate two measures of patient volume: annual diagnoses by provider (for 
use in aim 1 for facility of diagnosis) and unique patients cared for by provider (for use in aim 2 for facility 
of first viral suppression), as well as facility type (for aims 1 and 2). 
April 17, 2014 – Revising neighborhood variables 




Created additional variable of percent of population that did not graduate from high school for greater 
consistency with the literature.  Previously we had variables for percent finishing high school and percent 
finishing college.  Percent not graduating from high school was calculated as 100 - percent graduating 
from high school. 
Also divided all neighborhood variables by 10 so that, when modelled as continuous variables, the 
resulting measure of association would represent the hazard ratio for each 10-percentage-point increase 
in the variable.  For example, the percent not graduating high school was 60, but the percent not 
graduating high school divided by 10 was 6, and the latter variable was modelled, so the hazard ratio for 
each 1-point change in the latter variable represented a 10-percentage-point change. 
May 20, 2014 – Excluding persons with possibly misclassified diagnosis date 
SAS 
Several edits were made between February 5 and May 21 but not documented here, including the 
reincorporation of provider XY data since many more had it after a March/April geocoding by Keyi Xu. 
On May 20, three exclusions were added to bring the population closely in line with that in Lucia Torian 
and Qiang Xia’s paper on viral suppression among newly diagnosed New Yorkers, which sought to 
remove persons whose diagnosis dates may have been misclassified.  These three exclusions were:  
1. Persons who did not have a Western blot within 31 days of diagnosis and were not acute HIV 
infections 
2. Persons who had a detectable (>50 copies/mL) viral load >31 days prior to HIV diagnosis 
3. Persons who had a suppressed (>400 copies/mL) viral load ≤31 days following HIV diagnosis 
This resulted in a reduction in our analysis population from 14,065 cases to 12,547 cases.  Proportion 
suppressed decreased from 73.8 to 72.8% and median time to suppression increased from 225 to 245 
days. 
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Appendix 4. Calculating shortest distance along NYC streets from patient 
residence at diagnosis to facility of diagnosis using Network Analyst in ArcGIS 
 
Created XY datasets. We created a single dataset that included variables for patient identifier (cityno), 
XY coordinates for patient residence at HIV diagnosis, and XY coordinates of the facility that diagnosed 
HIV in each patient.  We transferred this dataset from the most-secure drive to a less-secure drive that 
has ArcGIS on it.  We split this dataset into two, each with the patient identifier and each one having 
either patient or provider XY coordinates.  We copied cityno in each XY Excel file into a second column in 
each called RouteName.  We ensured that patient and provider XY were numeric.  We also deleted 
provider records with missing XY.  We named the files “ptxy20140313” and “provxy20140313.” 
Got Network Analyst. We opened ArcMap and in the Customize menu, selected Extensions – 
Network Analyst, then closed the window.  Then in the Customize menu again, we selected Toolbars – 
Network Analyst to get the toolbar for this extension. 
Obtained network dataset. We obtained the “MP_Network” network dataset of NYC streets.  This 
network dataset is a simple network of NYC streets without details that for our purposes would be 
extraneous, like which streets are one-way, as we are not interested in actual driving directions.  We used 
Add Data to add MP_Network and specifically NYC_Streets within it, and said “Yes” to also add to the 
map all feature classes that participate in the network dataset.  The Network Analyst toolbar now had in 
its “Network dataset” window “NYC_Streets_ND.”  Three layers showed up from this in the Table of 
Contents: lines, dots for junctions, and lines for edges. 
Added XY data to map. We clicked Add Data and added ptxy20140313 and provxy20140313 data 
from Excel, right-clicked on each to display XY data, and clicked Yes to add the data to the map as a 
layer (ptxy Events and provxy Events). 
Exported XY data to file geodatabase of network dataset. XY data are most easily routed in 
Network Analyst when saved within the file geodatabase of the network dataset.  With the ptxy Events 
layer, we right clicked, exported data, navigated to the MP_Network geodatabase folder, selected the 
geodatabase within that, named ptxy as a personal gdb/features class, closed, clicked Yes to add to map 
as layer, and deleted the original Events layer from the Table of Contents.  We did the same with the 
provxy Events layer.  Right-clicked on each to display XY data, and clicked Yes to add to the map as a 
layer. 
Established settings for routing. In the Network Analyst toolbar, clicked the arrow next to “Network 
Analyst” and selected New Route.  In the Table of Contents, immediately under the NYC_Streets layer, 
we right-clicked on Route  Properties  Analysis settings  Output shape type  Straight line.  
Routing as a straight line doesn’t affect the distance being calculated but may help the routing run faster 
in ArcMap. 
Loaded XY coordinates into Network Analyst. In the Network Analyst window, we right-clicked the 
Stops line and (after acknowledging with No that we didn’t want to repair the address locator) clicked 
Load Locations, then selected ptxy (the only one with that name in the Table of Contents), selected 
sorting by Routename, and checked that the Routename property was affiliated with the Routename field 
in our origins (patient) table.  We clicked OK, and this ran in about five minutes  We right-clicked Stops, 
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Load Locations, selected provxy, selected sorting by Routename, and confirmed Routename was 
affiliated with Routename field in table, clicked OK, and let ArcMap run for another five minutes. 
Calculated and reviewed distances. We clicked the Solve icon (a small square with gridlines and a 
blue line) in the Network Analyst toolbar and let it run for 15-30 minutes this time.  This calculated the 
distances between each person’s residence and facility of diagnosis, as well as created straight-line 
“routes” from each patient to his/her facility of diagnosis.  We displayed these on the map, added ZIP and 
borough shapefiles for context, and exported this map as a PNG image file, not for publication (XY patient 
locations are confidential) but for internal visual review.  We noted that nearly all of Manhattan was 
completely blanketed by routes, and most of the other boroughs were also largely covered. 
Saved dataset of distances. In the Network Analyst window, we right-clicked Routes  Data  
Export data  Use the same coordinate system as the data frame  Named it “PtProvDistance” and 
saved in the main (non-geodatabase) folder, and said Yes to add exported data to map as a layer.  Then 
in Windows Explorer, we opened the DBF that was just created that was affiliated with the shapefile, gave 
it another name and saved as Excel, kept only cityno and total length (shape length, which was slightly 
shorter, is the length of the straight-line route drawn between each patient’s residence and facility of 
diagnosis), and created new columns calculating equivalent miles and kilometers from the distance in 
feet. 
Removed data from less-secure drive. We deleted or transferred back to the most-secure drive all 
files on the less-secure drive related to the calculation of patient-provider distance. 
 
I found the following online resources helpful: 
ArcGis Network Analyst tutorial at http://help.arcgis.com/en/arcgisdesktop/10.0/pdf/network-analyst-
tutorial.pdf 
Post #3 in online forum at http://forums.arcgis.com/threads/30795-calculating-driving-distances  
 
I would like to acknowledge the following persons for their help with network analysis: 
Susan Resnick, NYC DOHMH DIIT, for providing network dataset and help with Network Analyst 
Andrew Maroko, Lehman College, CUNY, for providing help with Network Analyst, including remotely 
walking us through the actual routing 




Appendix 5. Assessing model fit for Aim 1 
 
An Excel table was made indicating the set of variables in each proportional hazards regression model.  The -2LL (with covariates) was 
recorded from SAS for each model.  The difference in -2LL and degrees of freedom were entered into a Χ2 calculator at 
https://www.fourmilab.ch/rpkp/experiments/analysis/chiCalc.html on February 4, 2015. We used the “Calculate probability from Χ2 and d” section of 
the webpage and manually copied each difference in -2LL, out to three significant digits, into the “Given Χ2=” box, entered each number of 
degrees of freedom into the “d=” box, and clicked “Calculate” to get a value in the “The chance probability, Q, is:” box.  For example, the model of 
time from diagnosis to viral suppression that had all three neighborhood-level variables in addition to the seven individual-level variables had a -
2LL of about 158,673, whereas the individual-only model’s -2LL was about 158,675, for a difference of 2.190 with three degrees of freedom (see 
Table A5.1).  The calculator indicated that the probability of getting a difference at least as large with these degrees of freedom was 0.5339, 
meaning that the addition of the three neighborhood-level variables did not statistically significantly improve the fit of the model over individual-
level variables alone.  The model of suppression that had the best fit was that with all individual- and facility-level variables, which had a -2LL of 
158,585 (p<0.0001). 
Table A5.1. Measures of the fit of proportional hazards models of HIV viral suppression among persons newly diagnosed 
with HIV in New York City in 2006-2010 and followed through 2012, by individual, facility, and neighborhood 
characteristics 
Variable Variable type Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 Model 9 
Age group (years) at 
diagnosis 
Individual x x x x x x x x x 
Sex at birth Individual x x x x x x x x x 
Race/Ethnicity Individual x x x x x x x x x 
Country of birth Individual x x x x x x x x x 




HIV transmission risk Individual x x x x x x x x x 
Year of HIV diagnosis Individual x x x x x x x x x 
Eligible for treatment Individual x x x x x x x x x 
Number of HIV diagnoses 
made annually by health 
care facility that 
diagnosed patient 
Facility  x  x      
Type of facility that 
diagnosed patient 
Facility  x   x     
Distance between patient 
and provider 
Facility  x    x    
Percent of population 
below federal poverty 
threshold in past 12 
months 
Neighborhood   x    x   
Unemployment rate 
among population 16 
years and over 
Neighborhood   x     x  
Percent of population that 
is black or African 
American only (non-
Hispanic) 
Neighborhood   x      x 
Measure of fit: -2LL ("with 
covariates") 
  158,675 158,585 158,673 158,642 158,626 158,663 158,673 158,675 158,675 
Comparison with model 
with all individual-level 
variables, using Χ2 
                    
Difference in -2LL  N/A 90.080 2.190 33.230 48.860 11.350 2.070 0.040 0.040 
Degrees of freedom  0 3 3 1 1 1 1 1 1 





Appendix 6. Patterns of viral load testing 
 
Of 12,547 persons in our analytic sample for Aim 1, i.e., persons newly diagnosed with HIV in 
2006-2010 whose address at diagnosis geocoded to an NYC Census tract, 1,446 (11.52%) had no viral 
load (VL) test between 8 days post-diagnosis and their censor date.  Thus, 88.5% (n=11,101) of persons 
in the analysis had at least one VL test ≥8 days after diagnosis (ranging only narrowly by diagnosis year: 
87-90% each year). 
Among this group of 11,101 persons, there were a median of 12 (IQR: 7-17) VL tests during 
follow-up (median of 17 [IQR: 10-23] among those diagnosed in 2006 and median of 8 [IQR: 5-10] among 
those diagnosed in 2010, for whom follow-up time was shorter), with a median interval of 112 (IQR: 90-
164) days (i.e., 3-4 months) between tests (median of 120 days [IQR: 95-182] among those diagnosed in 
2006 and median of 101 [IQR: 84-139] among those diagnosed in 2010).  Out of the 11,101 persons with 
at least one VL test ≥8 days after diagnosis, 19% had their first VL test within 14 days of diagnosis (i.e., 8-
14 days), 45% within 30 days, 67% within 60 days, 76% within 91 days, 87% within 183 days, 90% within 




Appendix 7. Young teenagers, facility type and patient volume, changes in 
residence over time, and model fit for Aim 2 
 
A7.1. Young teenagers 
The discussion argues that information about teenagers is unique because they are rarely 
included in analyses of viral suppression before 18 years of age.  To support this statement, I checked 
the number of persons in the analysis for Aim 2 who were aged 13-17 years at their first viral suppression 
after diagnosis.  I compared this number with the number of persons 18-19 years old at suppression and 
calculated the proportion of persons 13-19 years old (i.e., teenagers, one of the age groups in the 
analysis) who were 13-17.  I found that 55 of the teenagers were 13-17 years old, and 141 were 18-19 
years old (Table A7.1).  Thus, 13-17-year-olds comprised a non-negligible number of persons, and 28% 
of teenagers, in the analysis.  Based on this information, we will keep our argument about teenagers in 
the Discussion.  As an additional note, only 7 of the 13-17-year-olds were 13-15 years old; 48 were 16-
17. 
Table A7.1. Number of teenagers in analysis, by age group 
Age group at first viral suppression Number of teenagers in 
analysis 
Percentage of teenagers in 
analysis (%) 
13-17* 55 28 
  13-15*     7     4 
  16-17*   48   24 
18-19 141 72 
Total teenagers (13-19 years old) 196 100 
*These age groups are rarely presented in other analyses of viral suppression. 
 
A7.2. Facility type and patient volume  
We found that persons receiving care at facilities with small patient volumes had higher failure 
rates than those at facilities with larger patient volumes, and that persons receiving care at facilities that 
were not private physicians’ offices had higher failure rates than patients of private physicians, after 
controlling for individual and other facility or neighborhood characteristics.  To prevent confusion in the 
interpretation of these findings, it would be helpful to know if facility type and patient volume were 




tabulated facility type and patient volume among all 8,927 persons in the Aim 2 analysis population and 
conducted a Chi-squared test of association.  This analysis shows that, for most persons who were first 
suppressed at private physicians’ offices (850/1,564, 54%), their facilities saw fewer than 1,000 patients 
for HIV-related medical care that year, whereas for most persons who were first suppressed at an 
inpatient facility or hospital, their facilities saw at least 1,000 patients (3,865/4,879, 79%; Table A7.2).  
The Chi-squared test indicated a statistically significant association between facility type and patient 
volume (p<0.0001).  However, facility type and patient volume were not equivalent: most persons who 
first suppressed at facilities with patient volumes of <250 were not at private physicians’ offices.  The 
paper was revised so that the proportional hazards models use the combined variable rather than facility 
type and patient volume separately. 
 
Table A7.2. Number of persons first suppressed at each facility type, by patient volume 
Unique patients 
seen for care 
(CD4 or VL) at 
facility of first 
suppression in 
year of first 
suppression 










  N Col. % N Col. % N Col. % N Col. % N Col. % 
<250  116 2 884 38 850 54 101 54 1,951 22 
250 to <1,000  898 18 676 29 608 39 85 46 2,267 25 
1,000 to <2,000  2,020 41 216 9 106 7 0 0 2,342 26 
>=2,000  1,845 38 522 23 0 0 0 0 2,367 27 
Total N 4,879 100 2,298 100 1,564 100 186 100 8,927 100 
Total % Row % 55  26  18  2  100  
 
 
A7.3. Changes in residence over time 
Residence information from the time of HIV diagnosis was used to provide neighborhood-level 
data for persons in the analysis.  Address of residence was geocoded to the Census tract, which was 
then used to assign neighborhood poverty level, percent black, and percent unemployed.  Complete and 
accurate geocoding is labor-intensive, so we did not attempt to determine or geocode address at the time 




at first suppression were the same as those at diagnosis.  To better understand how this might affect the 
internal validity of our results, we assessed moves among NYC residents 13+ who were diagnosed in 
2006-2010 and would go on to achieve suppression ≥31 days after diagnosis and by the end of the 
follow-up period (12/31/2012).  In the October 2013 analytic dataset, this included 12,584 persons, quite a 
bit more than the dissertation Aim 2 analysis population of 8,927.  This may be because of the loss in the 
dissertation analysis of persons whose address at residence did not geocode, plus other exclusion 
criteria, which could not readily be included for this appendix analysis. 
Among these 12,584 persons, we compared the United Hospital Fund (UHF) neighborhood, 
borough, and ZIP-level poverty level of their residence at diagnosis with their UHF neighborhood, 
borough, or ZIP-level poverty level, respectively, as of the end of (a) their diagnosis year and (b) the next 
calendar year.  For example, for someone diagnosed anytime in 2007, we assessed whether the UHF at 
diagnosis was the same as the UHF as of the end of 2007 and the end of 2008, whether the borough at 
diagnosis was the same as the borough as of the end of 2007 and the end of 2008, and whether the 
poverty level of their ZIP code at diagnosis was the same as that of their ZIP code as of the end of 2007 
and the end of 2008.  We chose these measures because they were readily available and because 44% 
of persons in the main dissertation analysis for Aim 1 achieved viral suppression within 12 months of 
diagnosis.  The proportion of persons who would have moved by the time they achieved suppression may 
be estimated by the midpoint of the proportion of persons who moved by the end of diagnosis year (for 
whom median time elapsed would be six months) and the proportion of persons who moved by the end of 
the year after diagnosis (for whom median time elapsed would be 18 months).  Residence information in 
surveillance is updated largely based on laboratory test values; persons achieving suppression by 
definition would have had laboratory test values subsequent to diagnosis (although not necessarily within 
one calendar year after diagnosis). 
We assessed change in residence overall and by diagnosis year.  We found no large differences 
by diagnosis year in moves across UHFs, boroughs, or poverty levels, so Table A7.3 (below) presents 
statistics on changes in residence aggregated across diagnosis years.  Overall, 16% of persons had 
changed UHFs by the end of their diagnosis year and 27% by the end of the calendar year following their 




calendar year following their diagnosis, and 12% had changed poverty levels by the end of their diagnosis 
year and 21% by the end of the calendar year following their diagnosis.  Midpoints were 21% changing 
UHF, 10% changing borough, and 16% changing poverty level. 
UHFs are larger than Census tracts, suggesting that more than 21% of persons in our analysis 
may have changed Census tract of residence between diagnosis and suppression.  The cross-borough 
figures are more modest, but those and, to a greater extent, the cross-poverty figures suggest that many 
persons moved to places substantially different from those they were living in at diagnosis.  Similarly, in 
the dissertation Aim 2 analysis, many persons may have moved by the time they achieved suppression to 
Census tracts with different characteristics, e.g., poverty level, than the Census tracts they were living in 
at diagnosis.  Additionally, the rate of moving itself (>21%) suggests that the impact of neighborhoods on 
the achievement of viral suppression may be difficult to measure, as many persons live in more than one 
neighborhood between diagnosis and suppression, albeit sometimes similar neighborhoods.  Our 
longitudinal analysis, which uses information about residence at one time point only (and moreover, one 
that falls before the baseline), is somewhat limited in its ability to assess the role of neighborhood on 
participant outcomes. 
Table A7.3. Change in residence among New York City (NYC) residents who were newly 
diagnosed with HIV in 2006-2010 and achieved viral suppression by the end of 2012 
 
 Timing of the change  
Geographic level 
By end of 
diagnosis year 
(%) 
By end of year 
after diagnosis 
(%)  Midpoint (%) 
Moved to different UHF neighborhood 16   27 21 
Moved to different NYC borough 7 13 10 
Moved to ZIP code with different poverty level 12 21 16 






A7.4. Model fit for Aim 2 
Table A7.4. Measures of the fit of proportional hazards models of HIV virologic failure after suppression among persons 
newly diagnosed with HIV in New York City in 2006-2010 and followed through 2012, by individual, facility, and 
neighborhood characteristics 
Variable Variable type Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Age group (years) at 
suppression 
Individual x x x x x x x x 
Sex at birth Individual x x x x x x x x 
Race/Ethnicity Individual x x x x x x x x 
Country of birth Individual x x x x x x x x 
HIV transmission risk Individual x x x x x x x x 
Year of viral suppression Individual x x x x x x x x 
CD4 count Individual x x x x x x x x 
Facility type by patient 
volume 
Facility  x  x     
Distance between person 
and provider 
Facility  x   x    
Percent of population below 
federal poverty threshold in 
past 12 months 
Neighborhood   x   x   
Unemployment rate among 
population 16 years and over 
Neighborhood   x    x  
Percent of population that is 
black or African American 
only (non-Hispanic) 
Neighborhood   x     x 
Measure of fit: -2LL ("with 
covariates") 





Comparison with model with 
all individual-level variables, 
using Χ2 
                  
Difference in -2LL  N/A 70 19 69 4 16 8 2 
Degrees of freedom  0 2 3 1 1 1 1 1 





Appendix 8.  Clarifying and exploring the Aim 3-specific variable of perceived 
neighborhood social cohesion  
 
A8.1. How the Aim 3-specific variable of perceived neighborhood social cohesion was 
created 
 
Perceived neighborhood social cohesion was calculated based on the degree of participant 
agreement with three statements in the Case Surveillance-Based Sampling (CSBS) interview about trust, 
closeness, and helpfulness between neighbors. [45, 46]  These statements were:  
a. I live in a close-knit neighborhood. 
b. People in my neighborhood can be trusted 
c. People in my neighborhood are willing to help each other. 
Agreement with each statement were collected using a scored 1-4 Likert scale: strongly agree 
(1), agree (2), disagree (3), and strongly disagree (4).  Scores for the three responses were summed, and 
these sums of 3-12 were dichotomized near the median, at a natural break that would place 
approximately equivalent numbers of persons in each category.[46]  Specifically, the majority of sums 
were 6, 9, or 12 (>20% each), and 48% of persons had sums of 3-8 (see Table A8.1).  Lower scores 
indicated agreement with positive statements about the neighborhood; perceived neighborhood social 
cohesion was classified as high for persons with sums of 3-8 (48% of the sample population) and low for 
persons with sums of 9-12 (52% of the sample population; see Table A8.2). 





Table A8.1. Sums of responses to three cohesion-related questions in Case Surveillance-
Based Sampling interview, among 92 persons in analysis of viral suppression among 
newly diagnosed New York City residents 
cohesionOrig: Sum of three cohesion variables 




3 2 2.17 2 2.17 
5 3 3.26 5 5.43 
6 22 23.91 27 29.35 
7 8 8.70 35 38.04 
8 9 9.78 44 47.83 
9 22 23.91 66 71.74 
10 3 3.26 69 75.00 
11 4 4.35 73 79.35 
12 19 20.65 92 100.00 
  
Table A8.2. Dichotomized cohesion measure based on responses to three cohesion-
related questions in Case Surveillance-Based Sampling interview, among 92 persons in 
analysis of viral suppression among newly diagnosed New York City residents 
 
LowCohesion: Poor neighborhood social cohesion (cohesionOrig score is high: 9-12) 




0 44 47.83 44 47.83 
1 48 52.17 92 100.00 
  
 
A8.2 Cohesion as a three-level variable 
Perceived neighborhood social cohesion could have been categorized in a way that reflected the 
distribution of values differently.  Because most persons in our sample had cohesion scores of exactly 6, 
9, or 12, we constructed an alternative version of the cohesion variable with three levels rather than two.  
For this, cohesion was classified as low if the sum of the three cohesion variables was 10-12, medium if 




We ran a multivariable proportional hazards regression with this alternative version of the 
cohesion variable (see Table A8.3).  As with the original version of the variable, we found that increasing 
levels of cohesion were associated with reduced hazards of suppression, and that this association was 
still not statistically significant. 
Table A8.3. Proportional hazards regressions of 
HIV viral suppression among a stratified random 
sample of persons newly diagnosed with HIV in 
New York City in 2006-2012 who were 
interviewed and followed through June 2014, 
including perceived neighborhood social 
cohesion as a three-level variable 
    
AHR1                           
(95% CI)   
Perceived neighborhood social 
cohesion    
Low cohesion  1.00  
Medium cohesion  0.73 (0.42-1.28)  
High cohesion  0.69 (0.34-1.43)  
Age group (years) at diagnosis    
13 - 29  0.62 (0.35-1.08)  
≥30  1.00  
Sex at birth    
Male  0.93 (0.53-1.61)  
Female  1.00  
Race/Ethnicity    
Black or Hispanic  0.43 (0.21-0.85)  
Another race/ethnicity  1.00  
Year of HIV diagnosis    
2009 - 2009  0.60 (0.35-1.03)  
2010 - 2012  1.00  
Eligible for treatment    
Yes  1.00  
No  0.60 (0.36-0.99)  
Percent of population below 
federal poverty threshold in past 
12 months 
   
Low or medium (<20%)  1.00  
High or very high (≥20%)   1.00 (0.98-1.03)   





Appendix 9.  The creation of the Aim 3-specific variable for individual-level 
poverty, i.e., estimated poverty status 
 
Aim 3 was limited to persons interviewed by the Case Surveillance-Based Sampling project, 
which, unlike routine HIV surveillance in NYC, asked participants’ household size and income.  This 
provided a unique opportunity to assess poverty at the household/individual level.  (Both CSBS and 
routine HIV surveillance collect information about the place of residence of New Yorkers with HIV and can 
use residence data in combination with US Census Bureau data to assess neighborhood-level poverty.)  
In short, we combined US Census statistics on poverty thresholds by family size with self-reported 
household income from CSBS and number of persons who depended on the income (which we treated 
as a proxy for family size), to create a variable dichotomizing each person as poor or non-poor.  We 
called this measure “Estimated poverty status,” and this appendix provides more details about its 
creation. 
The relevant CSBS variables to create this poverty measure are described in the CSBS protocol’s 
Appendix D1, “2012/2013 Case-Surveillance-Based-Sampling Questionnaire for The Medical Monitoring 
Project (MMP)” (see Figure A9.1).  Monthly or yearly income was collected only as a range of values, not 





Figure A9.1. Questionnaire extract for income-related questions 
 
 
CSBS participants were asked to use a response card to indicate either their monthly or yearly 









Variables for monthly and yearly income had corresponding values, such that the lowest category 
of monthly income response would be equivalent to the lowest category of yearly income response, were 
that monthly income earned for 12 months (see Table A9.1).  For example, persons in households 







Table A9.1. Codebook of CSBS participant responses for monthly and yearly income and 
number of persons depending on the income 
MTH_IN12 8 
Monthly combined household 
income^[MTH_IN12] 1 (1)a.  $0 to $416 
      2 (2)b.  $417 to $833 
      3 (3)c.  $834 to $1249 
      4 
(4)d.  $1250 to 
$1666 
      5 
(5)e.  $1667 to 
$2499 
      6 (6)f.  $2500 to $3333 
      7 
(7)g.  $3334 to 
$4166 
      8 
(8)h.  $4167 to 
$6249 
      9 (9)i.  $6250 or more 
      D (D)Don't Know 
      S Skipped 
YR_IN12 8 
Yearly combined household 
income^[YR_IN12] 1 (1)j.  $0 to $4,999 
      2 
(2)k.  $5,000 to 
$9,999 
      3 
(3)l.  $10,000 to 
$14,999 
      4 
(4)m.  $15,000 to 
$19,999 
      5 
(5)n.  $20,000 to 
$29,999 
      6 
(6)o.  $30,000 to 
$39,999 
      7 
(7)p.  $40,000 to 
$49,999 
      8 
(8)q.  $50,000 to 
$74,999 
      9 
(9)r.  $75,000 or 
more 
      D (D)Don't Know 
      S Skipped 
DEPND_IN 8 
How many people depended on this 
income^[DEPND_IN] Nonmissing Numeric value 
      .S (S)Skipped 
      . Missing 
 
Because monthly and yearly income variables were coded in parallel fashion, because 




counted as poor, we created a variable for income category that took the larger value of either monthly or 
yearly income. 
We obtained a table of US poverty cutoffs from the Census Bureau based on family size (see 
Table A9.2).   
Table A9.2. Poverty Thresholds for 2013 by Size of Family and Number of Related 
Children Under 18 Years 
 
We used the weighted average thresholds from this table as income cutoffs.  However, these did 
not correspond perfectly with CSBS income categories.  We created an approximate crosswalk of Census 
thresholds and CSBS yearly household income (see Table A9.3).  Persons with a CSBS income category 
that was at or below the cutoff category were classified as poor.  We again erred on the side of being 
conservative, i.e., not classifying a family as poor if most of the values in an income range were above the 
poverty threshold for that family size.  For example, for one-person families, the poverty threshold was 
$11,888, and we linked this with CSBS income category 2.  This meant that any CSBS participant 
reporting CSBS income categories 1 or 2 (i.e., yearly income below $9,999) and stating that only one 
person was dependent on this income would be classified as poor.  CSBS participants reporting CSBS 
income category 3 (i.e., yearly income of $10,000-$14,999) with one person dependent on this income 
would be classified as non-poor, even though some of those persons may have had incomes between 
$10,000 and $11,888. 
  
One person (unrelated individual)....... 11,888      
  Under 65 years.............................. 12,119      12,119      
  65 years and over........................... 11,173      11,173      
Two people...................................... 15,142      
  Householder under 65 years........... 15,679      15,600      16,057      
  Householder 65 years and over........ 14,095      14,081      15,996      
Three people.................................... 18,552      18,222      18,751      18,769      
Four people..................................... 23,834      24,028      24,421      23,624      23,707      
Five people...................................... 28,265      28,977      29,398      28,498      27,801      27,376      
Six people........................................ 31,925      33,329      33,461      32,771      32,110      31,128      30,545      
Seven people................................... 36,384      38,349      38,588      37,763      37,187      36,115      34,865      33,493      
Eight people.................................... 40,484      42,890      43,269      42,490      41,807      40,839      39,610      38,331      38,006      
Nine people or more.......................... 48,065      51,594      51,844      51,154      50,575      49,625      48,317      47,134      46,842      45,037      
Source:  U.S. Census Bureau.






Size of family unit





Table A9.3. Approximate crosswalk of Census poverty thresholds and CSBS yearly 





Highest CSBS income 
category beneath the 
threshold (approx) 
1                      11,888                                              2  
2                      15,142                                              3  
3                      18,552                                              4  
4                      23,834                                              4  
5                      28,265                                              5  
6                      31,925                                              5  
7                      36,384                                              6  
8                      40,484                                              6  
9                      48,065                                              7  
 
This process permitted us to assign an estimated poverty status, i.e., an individual-level poverty 
measure, to each CSBS participant who answered interview questions about monthly or yearly household 
income and number of persons who depended on this income.  Persons missing any of this information 






Appendix 10. Assessing model fit for Aim 3 
Table A10.1. Measures of the fit of proportional hazards models of HIV viral suppression among a stratified random 
sample of persons newly diagnosed with HIV in New York City in 2006-2012 who were interviewed and followed through 



































































































































































































 N/A 0.553 8.133 10.119 2.912 0.031 0.996 0.084 1.007 0.995 0.086 0.921 4.039 0.576 0.030 0.659 
Degrees of 
freedom 
 0 1 1 1 1 1 1 1 2 1 1 1 4 1 1 2 
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